BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sgro C, Clinard F, Ouazir K, Chanay H, Allard C, Guilleminet C, Lenoir C, Lemoine A, Hillon P. Incidence of drug-induced hepatic injuries: A French population-based study: Incidence of drug-induced hepatic injuries: A French population-based study. Hepatology 2002;36:451-5. [DOI: 10.1053/jhep.2002.34857] [Cited by in Crossref: 504] [Cited by in F6Publishing: 387] [Article Influence: 28.0] [Reference Citation Analysis]
Number Citing Articles
1 Fontana RJ, Seeff LB, Andrade RJ, Björnsson E, Day CP, Serrano J, Hoofnagle JH. Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop. Hepatology 2010;52:730-42. [PMID: 20564754 DOI: 10.1002/hep.23696] [Cited by in Crossref: 191] [Cited by in F6Publishing: 164] [Article Influence: 17.4] [Reference Citation Analysis]
2 Stephens C, Robles-diaz M, Medina-caliz I, Garcia-cortes M, Ortega-alonso A, Sanabria-cabrera J, Gonzalez-jimenez A, Alvarez-alvarez I, Slim M, Jimenez-perez M, Gonzalez-grande R, Fernández MC, Casado M, Soriano G, Román E, Hallal H, Romero-gomez M, Castiella A, Conde I, Prieto M, Moreno-planas JM, Giraldez A, Moreno-sanfiel JM, Kaplowitz N, Lucena MI, Andrade RJ, Andrade R, Lucena M, Stephens C, Cortés MG, Robles-díaz M, Ortega-alonso A, Pinazo J, Muñoz BG, Alcántara R, Hernández A, Escaño MG, del Campo E, Medina-cáliz I, Sanabria-cabrera J, González-jiménez A, Sanjuán-jiménez R, Cueto A, Álvarez-álvarez I, Bonilla E, Di Zeo D, Niu H, Villanueva M, Papineau A, Pérez MJ, Grande RG, Ortega SL, Santaella I, Ocaña A, Palomino P, Fernández M, Peláez G, Porcel A, Casado M, Sánchez MG, Romero-gómez M, Millán-domínguez R, Fombuena B, Gallego R, Ampuero J, Campo JD, Calle-sanz R, Rojas L, Rojas A, Gómez AG, Vilar E, Soriano G, Guarner C, Román E, Manuitt MQ, Arbos RA, Delgado JS, Gómez MV, Hallal H, Oltra EG, Arcos JT, Martínez AP, Cobarro CS, Caparrós JE, Castiella A, Zapata E, Arenas J, García AG, Esandi F, Blanco S, Odriozola PM, Crespo J, Iruzubieta P, Cabezas J, Gallego AG, Rodríguez Seguel EDP, Cuaresma M, Gallego JG, Jorquera F, Campos SS, Otazua P, de Juan Gómez A, Salmerón J, Gila A, Quiles R, González J, Lorenzo S, Prieto M, Amiel IC, Berenguer M, García-eliz M, Primo J, Molés J, Garayoa A, Carrascosa M, Domínguez EG, Cuevas L, Farré M, Montané E, Barriocanal A, Arellano A, Sanz Y, Morillas R, Sala M, Ridaura HM, Bruguera M, Gines P, Lens S, García J, Mariño Z, Guerra MH, Sanfiel JM, Fernández del Campo CB, Tejedor M, Ferrer RG, Fernández C, Gil MF, Montero J, Mata MDL, Olmo JF, Bonilla EF, Moreno J, Martínez-rodenas P, Garrido M, Oliva C, Rendón P, Samaniego JG, Madejón A, Calleja J, Porras JM, Cabriada J, Pérez-moreno J, Lara C. Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry. Journal of Hepatology 2021;75:86-97. [DOI: 10.1016/j.jhep.2021.01.029] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
3 Tian Q, Yang R, Wang Y, Liu J, Wee A, Saxena R, Wang L, Li M, Liu L, Shan S, Kong Y, Ma H, Ou X, You H, Zhao X, Jia J. A High Serum Level of Taurocholic Acid Is Correlated With the Severity and Resolution of Drug-induced Liver Injury. Clin Gastroenterol Hepatol 2021;19:1009-1019.e11. [PMID: 32634627 DOI: 10.1016/j.cgh.2020.06.067] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Chang CY, Schiano TD. Review article: drug hepatotoxicity. Aliment Pharmacol Ther. 2007;25:1135-1151. [PMID: 17451560 DOI: 10.1111/j.1365-2036.2007.03307.x] [Cited by in Crossref: 140] [Cited by in F6Publishing: 97] [Article Influence: 10.0] [Reference Citation Analysis]
5 Antoine DJ, Harrill AH, Watkins PB, Park BK. Safety biomarkers for drug-induced liver injury – current status and future perspectives. Toxicol Res 2014;3:75-85. [DOI: 10.1039/c3tx50077b] [Cited by in Crossref: 12] [Article Influence: 1.7] [Reference Citation Analysis]
6 de Andrade KQ, Moura FA, dos Santos JM, de Araújo OR, de Farias Santos JC, Goulart MO. Oxidative Stress and Inflammation in Hepatic Diseases: Therapeutic Possibilities of N-Acetylcysteine. Int J Mol Sci 2015;16:30269-308. [PMID: 26694382 DOI: 10.3390/ijms161226225] [Cited by in Crossref: 115] [Cited by in F6Publishing: 86] [Article Influence: 19.2] [Reference Citation Analysis]
7 Holtmann G, Schrenk D, Madisch A, Allescher HD, Ulrich-Merzenich G, Mearin F, Larrey D, Malfertheiner P. Use of Evidence-Based Herbal Medicines for Patients with Functional Gastrointestinal Disorders: A Conceptional Framework for Risk-Benefit Assessment and Regulatory Approaches. Dig Dis 2020;38:269-79. [PMID: 31770769 DOI: 10.1159/000504570] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Fu T, Wang S, Liu J, Cai E, Li H, Li P, Zhao Y. Protective effects of α-mangostin against acetaminophen-induced acute liver injury in mice. European Journal of Pharmacology 2018;827:173-80. [DOI: 10.1016/j.ejphar.2018.03.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
9 Li X, Gao P, Niu J. Metabolic Comorbidities and Risk of Development and Severity of Drug-Induced Liver Injury. Biomed Res Int 2019;2019:8764093. [PMID: 31531370 DOI: 10.1155/2019/8764093] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
10 Jeong R, Lee YS, Sohn C, Jeon J, Ahn S, Lim KS. Model for end-stage liver disease score as a predictor of short-term outcome in patients with drug-induced liver injury. Scand J Gastroenterol. 2015;50:439-446. [PMID: 25639449 DOI: 10.3109/00365521.2014.958094] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
11 Nayudu SK, Badipatla S, Niazi M, Balar B. Cholestatic hepatitis with small duct injury associated with celecoxib. Case Rep Med 2013;2013:315479. [PMID: 23861685 DOI: 10.1155/2013/315479] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
12 Teschke R, Schwarzenboeck A, Hennermann KH. Kava hepatotoxicity: a clinical survey and critical analysis of 26 suspected cases. Eur J Gastroenterol Hepatol. 2008;20:1182-1193. [PMID: 18989142 DOI: 10.1097/meg.0b013e3283036768] [Cited by in Crossref: 89] [Cited by in F6Publishing: 25] [Article Influence: 6.8] [Reference Citation Analysis]
13 Hussaini SH, Farrington EA. Idiosyncratic drug-induced liver injury: an overview. Expert Opin Drug Saf. 2007;6:673-684. [PMID: 17967156 DOI: 10.1517/14740338.6.6.673] [Cited by in Crossref: 121] [Cited by in F6Publishing: 98] [Article Influence: 8.6] [Reference Citation Analysis]
14 Iruzubieta P, Arias-Loste MT, Barbier-Torres L, Martinez-Chantar ML, Crespo J. The Need for Biomarkers in Diagnosis and Prognosis of Drug-Induced Liver Disease: Does Metabolomics Have Any Role? Biomed Res Int 2015;2015:386186. [PMID: 26824035 DOI: 10.1155/2015/386186] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
15 Siramolpiwat S, Sakonlaya D. Clinical and histologic features of Azathioprine-induced hepatotoxicity. Scand J Gastroenterol 2017;52:876-80. [PMID: 28388864 DOI: 10.1080/00365521.2017.1311936] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
16 Lewis JH, Kleiner DE. Hepatic injury due to drugs, herbal compounds, chemicals and toxins. MacSween's Pathology of the Liver. Elsevier; 2012. pp. 645-760. [DOI: 10.1016/b978-0-7020-3398-8.00013-1] [Cited by in Crossref: 11] [Article Influence: 1.2] [Reference Citation Analysis]
17 Buzzetti E, Parikh PM, Gerussi A, Tsochatzis E. Gender differences in liver disease and the drug-dose gender gap. Pharmacol Res 2017;120:97-108. [PMID: 28336373 DOI: 10.1016/j.phrs.2017.03.014] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 7.5] [Reference Citation Analysis]
18 Kao WY, Su CW, Huang YS, Chou YC, Chen YC, Chung WH, Hou MC, Lin HC, Lee FY, Wu JC. Risk of oral antifungal agent-induced liver injury in Taiwanese. Br J Clin Pharmacol. 2014;77:180-189. [PMID: 23750489 DOI: 10.1111/bcp.12178] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 6.2] [Reference Citation Analysis]
19 Greenblatt HK, Greenblatt DJ. Liver injury associated with ketoconazole: review of the published evidence. J Clin Pharmacol. 2014;54:1321-1329. [PMID: 25216238 DOI: 10.1002/jcph.400] [Cited by in Crossref: 40] [Cited by in F6Publishing: 26] [Article Influence: 5.7] [Reference Citation Analysis]
20 Salvo F, De Sarro A, Caputi AP, Polimeni G. Amoxicillin and amoxicillin plus clavulanate: a safety review. Expert Opin Drug Saf 2009;8:111-8. [PMID: 19236222 DOI: 10.1517/14740330802527984] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
21 Rathi C, Pipaliya N, Patel R, Ingle M, Phadke A, Sawant P. Drug Induced Liver Injury at a Tertiary Hospital in India: Etiology, Clinical Features and Predictors of Mortality. Annals of Hepatology 2017;16:442-50. [DOI: 10.5604/01.3001.0009.8600] [Cited by in Crossref: 29] [Cited by in F6Publishing: 9] [Article Influence: 7.3] [Reference Citation Analysis]
22 Abid A, Subhani F, Kayani F, Awan S, Abid S. Drug induced liver injury is associated with high mortality-A study from a tertiary care hospital in Pakistan. PLoS One 2020;15:e0231398. [PMID: 32276267 DOI: 10.1371/journal.pone.0231398] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
23 Petronijevic M, Ilic K, Suzuki A. Drug induced hepatotoxicity: data from the Serbian pharmacovigilance database: REPORTING OF HEPATOTOXICITY IN SERBIA. Pharmacoepidem Drug Safe 2011;20:416-23. [DOI: 10.1002/pds.2115] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
24 Ahmad J, Odin JA. Epidemiology and Genetic Risk Factors of Drug Hepatotoxicity. Clin Liver Dis 2017;21:55-72. [PMID: 27842775 DOI: 10.1016/j.cld.2016.08.004] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
25 Sistanizad M, Peterson GM. Drug-induced liver injury in the Australian setting. J Clin Pharm Ther. 2013;38:115-120. [PMID: 23350857 DOI: 10.1111/jcpt.12039] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
26 Björnsson ES. Epidemiology, Predisposing Factors, and Outcomes of Drug-Induced Liver Injury. Clin Liver Dis 2020;24:1-10. [PMID: 31753242 DOI: 10.1016/j.cld.2019.08.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
27 Tajiri K, Shimizu Y. Practical guidelines for diagnosis and early management of drug-induced liver injury. World J Gastroenterol. 2008;14:6774-6785. [PMID: 19058303 DOI: 10.3748/wjg.14.6774] [Cited by in CrossRef: 102] [Cited by in F6Publishing: 81] [Article Influence: 8.5] [Reference Citation Analysis]
28 Saithanyamurthi H, Faust AJ. Drug-Induced Liver Disease: Clinical Course. Clin Liver Dis 2017;21:21-34. [PMID: 27842773 DOI: 10.1016/j.cld.2016.08.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
29 Andrade RJ, Robles M, Ulzurrun E, Lucena MI. Drug-induced liver injury: insights from genetic studies. Pharmacogenomics. 2009;10:1467-1487. [PMID: 19761370 DOI: 10.2217/pgs.09.111] [Cited by in Crossref: 74] [Cited by in F6Publishing: 59] [Article Influence: 6.2] [Reference Citation Analysis]
30 Jayaraman T, Lee YY, Chan WK, Mahadeva S. Epidemiological differences of common liver conditions between Asia and the West. JGH Open. 2020;4:332-339. [PMID: 32514433 DOI: 10.1002/jgh3.12275] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
31 Ruigómez A, Brauer R, Rodríguez LA, Huerta C, Requena G, Gil M, de Abajo F, Downey G, Bate A, Tepie MF, de Groot M, Schlienger R, Reynolds R, Klungel O. Ascertainment of acute liver injury in two European primary care databases. Eur J Clin Pharmacol 2014;70:1227-35. [PMID: 25066450 DOI: 10.1007/s00228-014-1721-y] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 3.9] [Reference Citation Analysis]
32 Rockey DC, Seeff LB, Rochon J, Freston J, Chalasani N, Bonacini M, Fontana RJ, Hayashi PH. Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method. Hepatology. 2010;51:2117-2126. [PMID: 20512999 DOI: 10.1002/hep.23577] [Cited by in Crossref: 233] [Cited by in F6Publishing: 182] [Article Influence: 21.2] [Reference Citation Analysis]
33 Stephens C, Lucena MI, Andrade RJ. Genetic risk factors in the development of idiosyncratic drug-induced liver injury. Expert Opinion on Drug Metabolism & Toxicology 2021;17:153-69. [DOI: 10.1080/17425255.2021.1854726] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
34 Kleiner DE. Drugs and Toxins. Macsween's Pathology of the Liver. Elsevier; 2018. pp. 673-779. [DOI: 10.1016/b978-0-7020-6697-9.00012-1] [Cited by in Crossref: 9] [Article Influence: 3.0] [Reference Citation Analysis]
35 Chughlay MF, Kramer N, Spearman CW, Werfalli M, Cohen K. N-acetylcysteine for non-paracetamol drug-induced liver injury: a systematic review. Br J Clin Pharmacol. 2016;81:1021-1029. [PMID: 26757427 DOI: 10.1111/bcp.12880] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
36 Björnsson E. Review article: drug-induced liver injury in clinical practice. Aliment Pharmacol Ther. 2010;32:3-13. [PMID: 20374223 DOI: 10.1111/j.1365-2036.2010.04320.x] [Cited by in Crossref: 84] [Cited by in F6Publishing: 71] [Article Influence: 7.6] [Reference Citation Analysis]
37 Russo MW, Galanko JA, Shrestha R, Fried MW, Watkins P. Liver transplantation for acute liver failure from drug induced liver injury in the United States. Liver Transpl. 2004;10:1018-1023. [PMID: 15390328 DOI: 10.1002/lt.20204] [Cited by in Crossref: 311] [Cited by in F6Publishing: 253] [Article Influence: 18.3] [Reference Citation Analysis]
38 Björnsson ES. Drug-induced liver injury: an overview over the most critical compounds. Arch Toxicol. 2015;89:327-334. [PMID: 25618544 DOI: 10.1007/s00204-015-1456-2] [Cited by in Crossref: 71] [Cited by in F6Publishing: 57] [Article Influence: 11.8] [Reference Citation Analysis]
39 Bjornsson ES, Jonasson JG. Drug-induced cholestasis. Clin Liver Dis. 2013;17:191-209. [PMID: 23540497 DOI: 10.1016/j.cld.2012.11.002] [Cited by in Crossref: 43] [Cited by in F6Publishing: 28] [Article Influence: 4.8] [Reference Citation Analysis]
40 Ferrajolo C, Scavone C, Donati M, Bortolami O, Stoppa G, Motola D, Vannacci A, Mugelli A, Leone R, Capuano A; DILI-IT Study Group. Antidepressant-Induced Acute Liver Injury: A Case-Control Study in an Italian Inpatient Population. Drug Saf 2018;41:95-102. [PMID: 28770534 DOI: 10.1007/s40264-017-0583-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
41 Alhaddad O, Elsabaawy M, Abdelsameea E, Abdallah A, Shabaan A, Ehsan N, Elrefaey A, Elsabaawy D, Salama M. Presentations, Causes and Outcomes of Drug-Induced Liver Injury in Egypt. Sci Rep 2020;10:5124. [PMID: 32198411 DOI: 10.1038/s41598-020-61872-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
42 Middelkoop MA, Bet PM, Drenth JPH, Huirne JAF, Hehenkamp WJK. Risk-efficacy balance of ulipristal acetate compared to surgical alternatives. Br J Clin Pharmacol 2021;87:2685-97. [PMID: 33341097 DOI: 10.1111/bcp.14708] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
43 Lapeyre-Mestre M, de Castro AM, Bareille MP, Del Pozo JG, Requejo AA, Arias LM, Montastruc JL, Carvajal A. Non-steroidal anti-inflammatory drug-related hepatic damage in France and Spain: analysis from national spontaneous reporting systems. Fundam Clin Pharmacol. 2006;20:391-395. [PMID: 16867024 DOI: 10.1111/j.1472-8206.2006.00416.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
44 Shavadia JS, Sharma A, Gu X, Neaton J, Deleve L, Holmes D, Home P, Eckel RH, Watkins PB, Granger CB. Determination of fasiglifam-induced liver toxicity: Insights from the data monitoring committee of the fasiglifam clinical trials program. Clinical Trials 2019;16:253-62. [DOI: 10.1177/1740774519836766] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
45 Ulcickas Yood M, Bortolini M, Casso D, Beck JG, Oliveria SA, Wells KE, Woodcroft KJ, Wang LI. Incidence of liver injury among cancer patients receiving chemotherapy in an integrated health system. Pharmacoepidemiol Drug Saf. 2015;24:427-434. [PMID: 25683797 DOI: 10.1002/pds.3757] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
46 Teschke R, Bahre R. Severe hepatotoxicity by Indian Ayurvedic herbal products: a structured causality assessment. Ann Hepatol. 2009;8:258-266. [PMID: 19841509 DOI: 10.1016/s1665-2681(19)31777-6] [Cited by in Crossref: 60] [Article Influence: 5.5] [Reference Citation Analysis]
47 Vorrink SU, Ullah S, Schmidt S, Nandania J, Velagapudi V, Beck O, Ingelman-Sundberg M, Lauschke VM. Endogenous and xenobiotic metabolic stability of primary human hepatocytes in long-term 3D spheroid cultures revealed by a combination of targeted and untargeted metabolomics. FASEB J 2017;31:2696-708. [PMID: 28264975 DOI: 10.1096/fj.201601375R] [Cited by in Crossref: 75] [Cited by in F6Publishing: 30] [Article Influence: 18.8] [Reference Citation Analysis]
48 Tiwari S, Mishra M, Salemi MR, Phinney BS, Newens JL, Gomes AV. Gender-specific changes in energy metabolism and protein degradation as major pathways affected in livers of mice treated with ibuprofen. Sci Rep 2020;10:3386. [PMID: 32099006 DOI: 10.1038/s41598-020-60053-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
49 Lally J, al Kalbani H, Krivoy A, Murphy KC, Gaughran F, Maccabe JH. Hepatitis, Interstitial Nephritis, and Pancreatitis in Association With Clozapine Treatment: A Systematic Review of Case Series and Reports. J Clin Psychopharmacol 2018;38:520-7. [DOI: 10.1097/jcp.0000000000000922] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 3.7] [Reference Citation Analysis]
50 Seife Hassen S, Ata F, Bint I Bilal A, Salih Ali M, Petkar M, Awad Elzouki AY, Zahid M. Immune-mediated drug-induced liver injury secondary to Omeprazole: A case report. Clin Case Rep 2020;8:3421-6. [PMID: 33363945 DOI: 10.1002/ccr3.3421] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
51 Ott LM, Ramachandran K, Stehno-Bittel L. An Automated Multiplexed Hepatotoxicity and CYP Induction Assay Using HepaRG Cells in 2D and 3D. SLAS Discov 2017;22:614-25. [PMID: 28346810 DOI: 10.1177/2472555217701058] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
52 Lo Re V, Haynes K, Forde KA, Goldberg DS, Lewis JD, Carbonari DM, Leidl KB, Reddy KR, Nezamzadeh MS, Roy J. Risk of Acute Liver Failure in Patients With Drug-Induced Liver Injury: Evaluation of Hy’s Law and a New Prognostic Model. Clin Gastroenterol Hepatol. 2015;13:2360-2368. [PMID: 26122767 DOI: 10.1016/j.cgh.2015.06.020] [Cited by in Crossref: 36] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
53 O'connor N, Dargan P, Jones A. Hepatocellular damage from non-steroidal anti-inflammatory drugs. QJM: An International Journal of Medicine 2003;96:787-91. [DOI: 10.1093/qjmed/hcg138] [Cited by in Crossref: 95] [Cited by in F6Publishing: 67] [Article Influence: 5.3] [Reference Citation Analysis]
54 Nakaharai K, Sakamoto Y, Yaita K, Yoshimura Y, Igarashi S, Tachikawa N. Drug-induced liver injury associated with high-dose ceftriaxone: a retrospective cohort study adjusted for the propensity score. Eur J Clin Pharmacol 2016;72:1003-11. [PMID: 27126206 DOI: 10.1007/s00228-016-2064-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
55 Reuben A, Koch DG, Lee WM; Acute Liver Failure Study Group. Drug-induced acute liver failure: results of a U.S. multicenter, prospective study. Hepatology. 2010;52:2065-2076. [PMID: 20949552 DOI: 10.1002/hep.23937] [Cited by in Crossref: 440] [Cited by in F6Publishing: 329] [Article Influence: 40.0] [Reference Citation Analysis]
56 Amacher DE. Female gender as a susceptibility factor for drug-induced liver injury. Hum Exp Toxicol. 2014;33:928-939. [PMID: 24299907 DOI: 10.1177/0960327113512860] [Cited by in Crossref: 39] [Cited by in F6Publishing: 30] [Article Influence: 4.9] [Reference Citation Analysis]
57 Treeprasertsuk S, Huntrakul J, Ridtitid W, Kullavanijaya P, Björnsson ES. The predictors of complications in patients with drug-induced liver injury caused by antimicrobial agents. Aliment Pharmacol Ther 2010;31:1200-7. [PMID: 20222907 DOI: 10.1111/j.1365-2036.2010.04292.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
58 Chintamaneni P, Stevenson HL, Malik SM. Bupivacaine drug-induced liver injury: a case series and brief review of the literature. Journal of Clinical Anesthesia 2016;32:137-41. [DOI: 10.1016/j.jclinane.2016.01.035] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.2] [Reference Citation Analysis]
59 Tajiri K, Shimizu Y. Practical guidelines for diagnosis and early management of drug-induced liver injury. World J Gastroenterol. 2008;14:6774-6785. [PMID: 19058303 DOI: 10.4748/wjg.14.6774] [Reference Citation Analysis]
60 Ghabril M, Fontana R, Rockey D, Jiezhun G, Chalasani N. Drug-induced liver injury caused by intravenously administered medications: the Drug-induced Liver Injury Network experience. J Clin Gastroenterol. 2013;47:553-558. [PMID: 23388845 DOI: 10.1097/mcg.0b013e318276bf00] [Cited by in Crossref: 17] [Cited by in F6Publishing: 5] [Article Influence: 2.1] [Reference Citation Analysis]
61 Lewis JH. The Art and Science of Diagnosing and Managing Drug-induced Liver Injury in 2015 and Beyond. Clin Gastroenterol Hepatol. 2015;13:2173-2189.e8. [PMID: 26116527 DOI: 10.1016/j.cgh.2015.06.017] [Cited by in Crossref: 47] [Cited by in F6Publishing: 37] [Article Influence: 7.8] [Reference Citation Analysis]
62 Sanchez-matienzo D, Arana A, Castellsague J, Perez-gutthann S. Hepatic disorders in patients treated with COX-2 selective inhibitors or nonselective NSAIDs: A case/noncase analysis of spontaneous reports. Clinical Therapeutics 2006;28:1123-32. [DOI: 10.1016/j.clinthera.2006.08.014] [Cited by in Crossref: 23] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
63 Billioti de Gage S, Collin C, Le-Tri T, Pariente A, Bégaud B, Verdoux H, Dray-Spira R, Zureik M. Antidepressants and Hepatotoxicity: A Cohort Study among 5 Million Individuals Registered in the French National Health Insurance Database. CNS Drugs 2018;32:673-84. [PMID: 29959758 DOI: 10.1007/s40263-018-0537-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
64 Kullak-Ublick GA, Andrade RJ, Merz M, End P, Benesic A, Gerbes AL, Aithal GP. Drug-induced liver injury: recent advances in diagnosis and risk assessment. Gut 2017;66:1154-64. [PMID: 28341748 DOI: 10.1136/gutjnl-2016-313369] [Cited by in Crossref: 196] [Cited by in F6Publishing: 148] [Article Influence: 49.0] [Reference Citation Analysis]
65 Teschke R, Danan G. Causality Assessment Methods in Drug-Induced Liver Injury. In: Chen M, Will Y, editors. Drug-Induced Liver Toxicity. New York: Springer; 2018. pp. 555-94. [DOI: 10.1007/978-1-4939-7677-5_27] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 3.7] [Reference Citation Analysis]
66 Weber S, Benesic A, Rotter I, Gerbes AL. Early ALT response to corticosteroid treatment distinguishes idiosyncratic drug-induced liver injury from autoimmune hepatitis. Liver Int 2019;39:1906-17. [PMID: 31319011 DOI: 10.1111/liv.14195] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
67 Vega M, Verma M, Beswick D, Bey S, Hossack J, Merriman N, Shah A, Navarro V;  Drug Induced Liver Injury Network (DILIN). The Incidence of Drug- and Herbal and Dietary Supplement-Induced Liver Injury: Preliminary Findings from Gastroenterologist-Based Surveillance in the Population of the State of Delaware. Drug Saf. 2017;40:783-787. [PMID: 28555362 DOI: 10.1007/s40264-017-0547-9] [Cited by in Crossref: 51] [Cited by in F6Publishing: 39] [Article Influence: 17.0] [Reference Citation Analysis]
68 Wang R, Qi X, Yoshida EM, Méndez-sánchez N, Teschke R, Sun M, Liu X, Su C, Deng J, Deng H, Hou F, Guo X. Clinical characteristics and outcomes of traditional Chinese medicine-induced liver injury: a systematic review. Expert Review of Gastroenterology & Hepatology 2018;12:425-34. [DOI: 10.1080/17474124.2018.1427581] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 8.0] [Reference Citation Analysis]
69 Vincenzi B, Russo A, Terenzio A, Galvano A, Santini D, Vorini F, Antonelli-Incalzi R, Vespasiani-Gentilucci U, Tonini G. The use of SAMe in chemotherapy-induced liver injury. Crit Rev Oncol Hematol 2018;130:70-7. [PMID: 30196914 DOI: 10.1016/j.critrevonc.2018.06.019] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 3.7] [Reference Citation Analysis]
70 Datta A, Flynn NR, Barnette DA, Woeltje KF, Miller GP, Swamidass SJ. Machine learning liver-injuring drug interactions with non-steroidal anti-inflammatory drugs (NSAIDs) from a retrospective electronic health record (EHR) cohort. PLoS Comput Biol 2021;17:e1009053. [PMID: 34228716 DOI: 10.1371/journal.pcbi.1009053] [Reference Citation Analysis]
71 Hilscher MB, Kamath PS, Eaton JE. Cholestatic Liver Diseases: A Primer for Generalists and Subspecialists. Mayo Clin Proc 2020;95:2263-79. [PMID: 33012354 DOI: 10.1016/j.mayocp.2020.01.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
72 Vargas JI, Arab JP, Bessone F, Lucena MI, Andrade RJ, Arrese M. Hepatotoxicity in Patients with Metabolic Syndrome: Causes and Consequences. Curr Hepatology Rep 2017;16:286-92. [DOI: 10.1007/s11901-017-0380-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
73 Wang Z, Liang X, Yu J, Zheng X, Zhu Y, Yan Y, Dong N, Di L, Song G, Zhou X, Wang X, Yang H, Ren J, Lyerly HK. Non-genetic risk factors and predicting efficacy for docetaxel--drug-induced liver injury among metastatic breast cancer patients. J Gastroenterol Hepatol 2012;27:1348-52. [PMID: 22432938 DOI: 10.1111/j.1440-1746.2012.07131.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
74 Urban TJ, Goldstein DB, Watkins PB. Genetic basis of susceptibility to drug-induced liver injury: what have we learned and where do we go from here? Pharmacogenomics 2012;13:735-8. [PMID: 22594502 DOI: 10.2217/pgs.12.45] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
75 Kaplowitz N. Drug-Induced Liver Injury. Drug-Induced Liver Disease. Elsevier; 2013. pp. 3-14. [DOI: 10.1016/b978-0-12-387817-5.00001-7] [Cited by in Crossref: 26] [Article Influence: 3.3] [Reference Citation Analysis]
76 Chalhoub WM, Sliman KD, Arumuganathan M, Lewis JH. Drug-induced liver injury: what was new in 2013? Expert Opin Drug Metab Toxicol. 2014;10:959-980. [PMID: 24746272 DOI: 10.1517/17425255.2014.909408] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
77 Sutti S, Tacke F. Liver inflammation and regeneration in drug-induced liver injury: sex matters! Clin Sci (Lond) 2018;132:609-13. [PMID: 29545336 DOI: 10.1042/CS20171313] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 3.7] [Reference Citation Analysis]
78 Cirulli ET, Nicoletti P, Abramson K, Andrade RJ, Bjornsson ES, Chalasani N, Fontana RJ, Hallberg P, Li YJ, Lucena MI, Long N, Molokhia M, Nelson MR, Odin JA, Pirmohamed M, Rafnar T, Serrano J, Stefánsson K, Stolz A, Daly AK, Aithal GP, Watkins PB; Drug-Induced Liver Injury Network (DILIN) investigators., International DILI consortium (iDILIC). A Missense Variant in PTPN22 is a Risk Factor for Drug-induced Liver Injury. Gastroenterology 2019;156:1707-1716.e2. [PMID: 30664875 DOI: 10.1053/j.gastro.2019.01.034] [Cited by in Crossref: 52] [Cited by in F6Publishing: 40] [Article Influence: 26.0] [Reference Citation Analysis]
79 Yamazaki Y, Kakizaki S, Horiguchi N, Takagi H, Mori M, Negishi M. Role of nuclear receptor CAR in carbon tetrachloride-induced hepatotoxicity. World J Gastroenterol 2005;11:5966-72. [PMID: 16273607 DOI: 10.3748/wjg.v11.i38.5966] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
80 Björnsson HK, Gudmundsson DO, Björnsson ES. Liver injury caused by oral anticoagulants: A population-based retrospective cohort study. Liver Int 2020;40:1895-900. [PMID: 32511827 DOI: 10.1111/liv.14559] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 9.0] [Reference Citation Analysis]
81 Bessone F, Hernandez N, Tagle M, Arrese M, Parana R, Méndez-Sánchez N, Ridruejo E, Mendizabal M, Dagher L, Contreras F, Fassio E, Pesoa M, Brahm J, Silva M. Drug-induced liver injury: A management position paper from the Latin American Association for Study of the liver. Ann Hepatol 2021;24:100321. [PMID: 33609753 DOI: 10.1016/j.aohep.2021.100321] [Reference Citation Analysis]
82 Sandhu N, Navarro V. Drug-Induced Liver Injury in GI Practice. Hepatol Commun. 2020;4:631-645. [PMID: 32363315 DOI: 10.1002/hep4.1503] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 11.0] [Reference Citation Analysis]
83 Tischer S, Fontana RJ. Drug-drug interactions with oral anti-HCV agents and idiosyncratic hepatotoxicity in the liver transplant setting. J Hepatol 2014;60:872-84. [PMID: 24280292 DOI: 10.1016/j.jhep.2013.11.013] [Cited by in Crossref: 51] [Cited by in F6Publishing: 40] [Article Influence: 6.4] [Reference Citation Analysis]
84 Alempijevic T, Zec S, Milosavljevic T. Drug-induced liver injury: Do we know everything? World J Hepatol. 2017;9:491-502. [PMID: 28443154 DOI: 10.4254/wjh.v9.i10.491] [Cited by in Crossref: 36] [Cited by in F6Publishing: 22] [Article Influence: 9.0] [Reference Citation Analysis]
85 Villanueva-Paz M, Morán L, López-Alcántara N, Freixo C, Andrade RJ, Lucena MI, Cubero FJ. Oxidative Stress in Drug-Induced Liver Injury (DILI): From Mechanisms to Biomarkers for Use in Clinical Practice. Antioxidants (Basel) 2021;10:390. [PMID: 33807700 DOI: 10.3390/antiox10030390] [Reference Citation Analysis]
86 Stine JG, Sateesh P, Lewis JH. Drug-induced liver injury in the elderly. Curr Gastroenterol Rep. 2013;15:299. [PMID: 23250699 DOI: 10.1007/s11894-012-0299-8] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
87 McIntyre RS, Panjwani ZD, Nguyen HT, Woldeyohannes HO, Alsuwaidan M, Soczynska JK, Lourenco MT, Konarski JZ, Kennedy SH. The hepatic safety profile of duloxetine: a review. Expert Opin Drug Metab Toxicol. 2008;4:281-285. [PMID: 18363543 DOI: 10.1517/17425255.4.3.281] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 2.7] [Reference Citation Analysis]
88 Li B, Wang Z, Fang JJ, Xu CY, Chen WX. Evaluation of prognostic markers in severe drug-induced liver disease. World J Gastroenterol 2007;13:628-32. [PMID: 17278233 DOI: 10.3748/wjg.v13.i4.628] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
89 Cheng YL, Wang YJ, Kao WY, Chen PH, Huo TI, Huang YH, Lan KH, Su CW, Chan WL, Lin HC, Lee FY, Wu JC. Inverse association between hepatitis B virus infection and fatty liver disease: a large-scale study in populations seeking for check-up. PLoS One. 2013;8:e72049. [PMID: 23991037 DOI: 10.1371/journal.pone.0072049] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 6.1] [Reference Citation Analysis]
90 Teschke R, Danan G. Drug induced liver injury with analysis of alternative causes as confounding variables. Br J Clin Pharmacol 2018;84:1467-77. [PMID: 29607530 DOI: 10.1111/bcp.13593] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 10.0] [Reference Citation Analysis]
91 Hebels DG, Jetten MJ, Aerts HJ, Herwig R, Theunissen DH, Gaj S, van Delft JH, Kleinjans JC. Evaluation of database-derived pathway development for enabling biomarker discovery for hepatotoxicity. Biomarkers in Medicine 2014;8:185-200. [DOI: 10.2217/bmm.13.154] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
92 Boelsterli UA. Mechanisms Underlying the Hepatotoxicity of Nonsteroidal Antiinflammatory Drugs. Drug-Induced Liver Disease. Elsevier; 2013. pp. 343-67. [DOI: 10.1016/b978-0-12-387817-5.00021-2] [Cited by in Crossref: 8] [Article Influence: 1.0] [Reference Citation Analysis]
93 Bergman E, Forsell P, Tevell A, Persson EM, Hedeland M, Bondesson U, Knutson L, Lennernäs H. Biliary secretion of rosuvastatin and bile acids in humans during the absorption phase. European Journal of Pharmaceutical Sciences 2006;29:205-14. [DOI: 10.1016/j.ejps.2006.04.015] [Cited by in Crossref: 49] [Cited by in F6Publishing: 36] [Article Influence: 3.3] [Reference Citation Analysis]
94 Meier Y, Cavallaro M, Roos M, Pauli-Magnus C, Folkers G, Meier PJ, Fattinger K. Incidence of drug-induced liver injury in medical inpatients. Eur J Clin Pharmacol. 2005;61:135-143. [PMID: 15726344 DOI: 10.1007/s00228-004-0888-z] [Cited by in Crossref: 124] [Cited by in F6Publishing: 102] [Article Influence: 7.8] [Reference Citation Analysis]
95 Lee MH, Graham GG, Williams KM, Day RO. A benefit-risk assessment of benzbromarone in the treatment of gout. Was its withdrawal from the market in the best interest of patients? Drug Saf. 2008;31:643-665. [PMID: 18636784 DOI: 10.2165/00002018-200831080-00002] [Cited by in Crossref: 166] [Cited by in F6Publishing: 123] [Article Influence: 12.8] [Reference Citation Analysis]
96 García-Cortés M, Ortega-Alonso A, Lucena MI, Andrade RJ; Spanish Group for the Study of Drug-Induced Liver Disease (Grupo de Estudio para las Hepatopatías Asociadas a Medicamentos GEHAM).l. Drug-induced liver injury: a safety review. Expert Opin Drug Saf 2018;17:795-804. [PMID: 30059261 DOI: 10.1080/14740338.2018.1505861] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
97 Nathwani RA, Kaplowitz N. Drug hepatotoxicity. Clin Liver Dis 2006;10:207-17, vii. [PMID: 16971258 DOI: 10.1016/j.cld.2006.05.009] [Cited by in Crossref: 46] [Cited by in F6Publishing: 34] [Article Influence: 3.1] [Reference Citation Analysis]
98 Fontana RJ. Approaches to the Study of Drug-Induced Liver Injury. Clin Pharmacol Ther 2010;88:416-9. [DOI: 10.1038/clpt.2010.100] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
99 Andrews E, Armstrong M, Tugwood J, Swan D, Glaves P, Pirmohamed M, Aithal GP, Wright MC, Day CP, Daly AK. A role for the pregnane X receptor in flucloxacillin-induced liver injury. Hepatology. 2010;51:1656-1664. [PMID: 20222094 DOI: 10.1002/hep.23549] [Cited by in Crossref: 48] [Cited by in F6Publishing: 38] [Article Influence: 4.4] [Reference Citation Analysis]
100 Kramer O, Albrecht J. Clinical presentation of terbinafine‐induced severe liver injury and the value of laboratory monitoring: a Critically Appraised Topic. Br J Dermatol 2017;177:1279-84. [DOI: 10.1111/bjd.15854] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
101 Andrade RJ, Camargo R, Lucena MI, González-Grande R. Causality assessment in drug-induced hepatotoxicity. Expert Opin Drug Saf. 2004;3:329-344. [PMID: 15268650 DOI: 10.1517/14740338.3.4.329] [Cited by in Crossref: 54] [Cited by in F6Publishing: 47] [Article Influence: 3.4] [Reference Citation Analysis]
102 Polson JE. Hepatotoxicity due to antibiotics. Clin Liver Dis 2007;11:549-61, vi. [PMID: 17723919 DOI: 10.1016/j.cld.2007.06.009] [Cited by in Crossref: 36] [Cited by in F6Publishing: 28] [Article Influence: 2.6] [Reference Citation Analysis]
103 Olsson R, Brunlof G, Johansson M, Persson M. Drug-induced hepatic injury in Sweden. Hepatology;38:531-2. [DOI: 10.1053/jhep.2003.50284] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
104 Fan WL, Shiao MS, Hui RC, Su SC, Wang CW, Chang YC, Chung WH. HLA Association with Drug-Induced Adverse Reactions. J Immunol Res 2017;2017:3186328. [PMID: 29333460 DOI: 10.1155/2017/3186328] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 8.5] [Reference Citation Analysis]
105 Shen T, Liu Y, Shang J, Xie Q, Li J, Yan M, Xu J, Niu J, Liu J, Watkins PB, Aithal GP, Andrade RJ, Dou X, Yao L, Lv F, Wang Q, Li Y, Zhou X, Zhang Y, Zong P, Wan B, Zou Z, Yang D, Nie Y, Li D, Wang Y, Han X, Zhuang H, Mao Y, Chen C. Incidence and Etiology of Drug-Induced Liver Injury in Mainland China. Gastroenterology. 2019;156:2230-2241.e11. [PMID: 30742832 DOI: 10.1053/j.gastro.2019.02.002] [Cited by in Crossref: 124] [Cited by in F6Publishing: 101] [Article Influence: 62.0] [Reference Citation Analysis]
106 Eiden C, Ripault MP, Larrey D, Faillie JL, Pinzani V, Pageaux GP, Peyrière H. Acute hepatitis and renal failure related to intranasal buprenorphine misuse: case report and analysis of cases reported to the French network for drug monitoring. Ann Pharmacother 2013;47:1721-6. [PMID: 24259614 DOI: 10.1177/1060028013507429] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
107 Chalasani N, Björnsson E. Risk factors for idiosyncratic drug-induced liver injury. Gastroenterology. 2010;138:2246-2259. [PMID: 20394749 DOI: 10.1053/j.gastro.2010.04.001] [Cited by in Crossref: 202] [Cited by in F6Publishing: 163] [Article Influence: 18.4] [Reference Citation Analysis]
108 Melchart D, Hager S, Albrecht S, Dai J, Weidenhammer W, Teschke R. Herbal Traditional Chinese Medicine and suspected liver injury: A prospective study. World J Hepatol 2017;9:1141-57. [PMID: 29085558 DOI: 10.4254/wjh.v9.i29.1141] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 8.0] [Reference Citation Analysis]
109 Deng X, Luyendyk JP, Ganey PE, Roth RA. Inflammatory stress and idiosyncratic hepatotoxicity: hints from animal models. Pharmacol Rev 2009;61:262-82. [PMID: 19805476 DOI: 10.1124/pr.109.001727] [Cited by in Crossref: 94] [Cited by in F6Publishing: 78] [Article Influence: 8.5] [Reference Citation Analysis]
110 Larrey D. Foie, médicaments et agents chimiques. Gastroentérologie Clinique et Biologique 2009;33:1136-46. [DOI: 10.1016/j.gcb.2009.10.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
111 Fu S, Wu D, Jiang W, Li J, Long J, Jia C, Zhou T. Molecular Biomarkers in Drug-Induced Liver Injury: Challenges and Future Perspectives. Front Pharmacol 2019;10:1667. [PMID: 32082163 DOI: 10.3389/fphar.2019.01667] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 15.0] [Reference Citation Analysis]
112 Lin G, Luo D, Liu J, Wu X, Chen J, Huang Q, Su L, Zeng L, Wang H, Su Z. Hepatoprotective Effect of Polysaccharides Isolated from Dendrobium officinale against Acetaminophen-Induced Liver Injury in Mice via Regulation of the Nrf2-Keap1 Signaling Pathway. Oxid Med Cell Longev 2018;2018:6962439. [PMID: 30116489 DOI: 10.1155/2018/6962439] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 6.3] [Reference Citation Analysis]
113 . Drug-Induced Liver Disease. In: Kaplowitz N, Deleve L, editors. Drug-Induced Liver Disease, Second Edition. CRC Press; 2007. pp. 1-11. [DOI: 10.3109/9781420021141-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
114 Stahl S, Davies MR, Cook DI, Graham MJ. Nuclear hormone receptor-dependent regulation of hepatic transporters and their role in the adaptive response in cholestasis. Xenobiotica 2008;38:725-77. [DOI: 10.1080/00498250802105593] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
115 Andrade RJ, López-Ortega S, López-Vega MC, Robles M, Cueto I, Lucena MI. Idiosyncratic drug hepatotoxicity: a 2008 update. Expert Rev Clin Pharmacol 2008;1:261-76. [PMID: 24422651 DOI: 10.1586/17512433.1.2.261] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.9] [Reference Citation Analysis]
116 Thurin NH, Lassalle R, Schuemie M, Pénichon M, Gagne JJ, Rassen JA, Benichou J, Weill A, Blin P, Moore N, Droz-Perroteau C. Empirical assessment of case-based methods for identification of drugs associated with acute liver injury in the French National Healthcare System database (SNDS). Pharmacoepidemiol Drug Saf 2021;30:320-33. [PMID: 33099844 DOI: 10.1002/pds.5161] [Reference Citation Analysis]
117 Shen JX, Youhanna S, Zandi Shafagh R, Kele J, Lauschke VM. Organotypic and Microphysiological Models of Liver, Gut, and Kidney for Studies of Drug Metabolism, Pharmacokinetics, and Toxicity. Chem Res Toxicol 2020;33:38-60. [DOI: 10.1021/acs.chemrestox.9b00245] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
118 Zhao L, Wang Y, Zhang Y. The potential diagnostic and therapeutic applications of exosomes in drug-induced liver injury. Toxicol Lett 2021;337:68-77. [PMID: 33259895 DOI: 10.1016/j.toxlet.2020.11.021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
119 Björnsson HK, Olafsson S, Bergmann OM, Björnsson ES. A prospective study on the causes of notably raised alanine aminotransferase (ALT). Scandinavian Journal of Gastroenterology 2016;51:594-600. [DOI: 10.3109/00365521.2015.1121516] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
120 Hunt CM, Yuen NA, Stirnadel-Farrant HA, Suzuki A. Age-related differences in reporting of drug-associated liver injury: data-mining of WHO Safety Report Database. Regul Toxicol Pharmacol. 2014;70:519-526. [PMID: 25236535 DOI: 10.1016/j.yrtph.2014.09.007] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 4.7] [Reference Citation Analysis]
121 Björnsson E, Jerlstad P, Bergqvist A, Olsson R. Fulminant drug-induced hepatic failure leading to death or liver transplantation in Sweden. Scandinavian Journal of Gastroenterology 2009;40:1095-101. [DOI: 10.1080/00365520510023846] [Cited by in Crossref: 94] [Cited by in F6Publishing: 68] [Article Influence: 7.8] [Reference Citation Analysis]
122 Gluud C. Acute, serious drug-induced liver injury. Journal of Hepatology 2002;37:675-7. [DOI: 10.1016/s0168-8278(02)00312-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
123 Hassan A, Fontana RJ. The diagnosis and management of idiosyncratic drug-induced liver injury. Liver Int. 2019;39:31-41. [PMID: 30003672 DOI: 10.1111/liv.13931] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 5.7] [Reference Citation Analysis]
124 Horvatits T, Drolz A, Trauner M, Fuhrmann V. Liver Injury and Failure in Critical Illness. Hepatology 2019;70:2204-15. [PMID: 31215660 DOI: 10.1002/hep.30824] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 17.0] [Reference Citation Analysis]
125 Jing J, Teschke R. Traditional Chinese Medicine and Herb-induced Liver Injury: Comparison with Drug-induced Liver Injury. J Clin Transl Hepatol 2018;6:57-68. [PMID: 29577033 DOI: 10.14218/JCTH.2017.00033] [Cited by in Crossref: 32] [Cited by in F6Publishing: 21] [Article Influence: 8.0] [Reference Citation Analysis]
126 Vuppalanchi R, Liangpunsakul S, Chalasani N. Etiology of New-Onset Jaundice: How Often Is It Caused by Idiosyncratic Drug-Induced Liver Injury in The United States? Am J Gastroenterol 2007;102:558-62. [DOI: 10.1111/j.1572-0241.2006.01019.x] [Cited by in Crossref: 81] [Cited by in F6Publishing: 54] [Article Influence: 5.8] [Reference Citation Analysis]
127 Abboud G, Kaplowitz N. Drug-induced liver injury. Drug Saf. 2007;30:277-294. [PMID: 17408305 DOI: 10.2165/00002018-200730040-00001] [Cited by in Crossref: 197] [Cited by in F6Publishing: 159] [Article Influence: 14.1] [Reference Citation Analysis]
128 Metushi IG, Cai P, Dervovic D, Liu F, Lobach A, Nakagawa T, Uetrecht J. Development of a novel mouse model of amodiaquine-induced liver injury with a delayed onset. J Immunotoxicol 2015;12:247-60. [PMID: 25046026 DOI: 10.3109/1547691X.2014.934977] [Cited by in Crossref: 28] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
129 Elzagallaai AA, Rieder MJ. In vitro testing for diagnosis of idiosyncratic adverse drug reactions: Implications for pathophysiology. Br J Clin Pharmacol 2015;80:889-900. [PMID: 25199801 DOI: 10.1111/bcp.12505] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
130 Corsini A, Ganey P, Ju C, Kaplowitz N, Pessayre D, Roth R, Watkins PB, Albassam M, Liu B, Stancic S. Current challenges and controversies in drug-induced liver injury. Drug Saf. 2012;35:1099-1117. [PMID: 23137150 DOI: 10.2165/11632970-000000000-00000] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
131 Niu B, Lei X, Xu Q, Ju Y, Xu D, Mao L, Li J, Zheng Y, Sun N, Zhang X, Mao Y, Li X. Protecting mitochondria via inhibiting VDAC1 oligomerization alleviates ferroptosis in acetaminophen-induced acute liver injury. Cell Biol Toxicol 2021. [PMID: 34401974 DOI: 10.1007/s10565-021-09624-x] [Reference Citation Analysis]
132 Tujios S, Fontana RJ. Mechanisms of drug-induced liver injury: from bedside to bench. Nat Rev Gastroenterol Hepatol. 2011;8:202-211. [PMID: 21386809 DOI: 10.1038/nrgastro.2011.22] [Cited by in Crossref: 166] [Cited by in F6Publishing: 132] [Article Influence: 16.6] [Reference Citation Analysis]
133 Bao Y, Wang P, Shao X, Zhu J, Xiao J, Shi J, Zhang L, Zhu HJ, Ma X, Manautou JE, Zhong XB. Acetaminophen-Induced Liver Injury Alters Expression and Activities of Cytochrome P450 Enzymes in an Age-Dependent Manner in Mouse Liver. Drug Metab Dispos 2020;48:326-36. [PMID: 32094214 DOI: 10.1124/dmd.119.089557] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
134 Low EXS, Zheng Q, Chan E, Lim SG. Drug induced liver injury: East versus West - a systematic review and meta-analysis. Clin Mol Hepatol. 2020;26:142-154. [PMID: 31816676 DOI: 10.3350/cmh.2019.1003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
135 Massart J, Begriche K, Moreau C, Fromenty B. Role of nonalcoholic fatty liver disease as risk factor for drug-induced hepatotoxicity. J Clin Transl Res 2017;3:212-32. [PMID: 28691103 DOI: 10.18053/jctres.03.2017S1.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
136 Palmer M, Regev A, Lindor K, Avigan MI, Dimick-Santos L, Treem W, Marcinak JF, Lewis JH, Anania FA, Seekins D, Shneider BL, Chalasani N. Consensus guidelines: best practices for detection, assessment and management of suspected acute drug-induced liver injury occurring during clinical trials in adults with chronic cholestatic liver disease. Aliment Pharmacol Ther. 2020;51:90-109. [PMID: 31762074 DOI: 10.1111/apt.15579] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
137 Chalasani N, Fontana RJ, Bonkovsky HL, Watkins PB, Davern T, Serrano J, Yang H, Rochon J;  Drug Induced Liver Injury Network (DILIN). Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology 2008; 135: 1924-1934, 1934.e1-1934. e4. [PMID: 18955056 DOI: 10.1053/j.gastro.2008.09.011] [Cited by in Crossref: 553] [Cited by in F6Publishing: 446] [Article Influence: 42.5] [Reference Citation Analysis]
138 Sundaram V, Björnsson ES. Drug-induced cholestasis. Hepatol Commun 2017;1:726-35. [PMID: 29404489 DOI: 10.1002/hep4.1088] [Cited by in Crossref: 41] [Cited by in F6Publishing: 29] [Article Influence: 10.3] [Reference Citation Analysis]
139 Aithal GP, Watkins PB, Andrade RJ, Larrey D, Molokhia M, Takikawa H, Hunt CM, Wilke RA, Avigan M, Kaplowitz N, Bjornsson E, Daly AK. Case definition and phenotype standardization in drug-induced liver injury. Clin Pharmacol Ther. 2011;89:806-815. [PMID: 21544079 DOI: 10.1038/clpt.2011.58] [Cited by in Crossref: 495] [Cited by in F6Publishing: 407] [Article Influence: 49.5] [Reference Citation Analysis]
140 Shapiro MA, Lewis JH. Causality Assessment of Drug-Induced Hepatotoxicity: Promises and Pitfalls. Clinics in Liver Disease 2007;11:477-505. [DOI: 10.1016/j.cld.2007.06.003] [Cited by in Crossref: 91] [Cited by in F6Publishing: 69] [Article Influence: 6.5] [Reference Citation Analysis]
141 Giri S, Nieber K, Bader A. Hepatotoxicity and hepatic metabolism of available drugs: current problems and possible solutions in preclinical stages. Expert Opinion on Drug Metabolism & Toxicology 2010;6:895-917. [DOI: 10.1517/17425251003792521] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
142 Woo HJ, Kim HY, Choi ES, Cho YH, Kim Y, Lee JH, Jang E. Drug-induced liver injury: A 2-year retrospective study of 1169 hospitalized patients in a single medical center. Phytomedicine. 2015;22:1201-1205. [PMID: 26598920 DOI: 10.1016/j.phymed.2015.10.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
143 Blachier M, Leleu H, Peck-Radosavljevic M, Valla DC, Roudot-Thoraval F. The burden of liver disease in Europe: a review of available epidemiological data. J Hepatol. 2013;58:593-608. [PMID: 23419824 DOI: 10.1016/j.jhep.2012.12.005] [Cited by in Crossref: 744] [Cited by in F6Publishing: 622] [Article Influence: 93.0] [Reference Citation Analysis]
144 Teschke R, Schulze J, Eickhoff A, Danan G. Drug Induced Liver Injury: Can Biomarkers Assist RUCAM in Causality Assessment? Int J Mol Sci. 2017;18:E803. [PMID: 28398242 DOI: 10.3390/ijms18040803] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 9.5] [Reference Citation Analysis]
145 Baekdal M, Ytting H, Skalshøi Kjær M. Drug-induced liver injury: a cohort study on patients referred to the Danish transplant center over a five year period. Scand J Gastroenterol 2017;52:450-4. [PMID: 27973926 DOI: 10.1080/00365521.2016.1267790] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
146 Danan G, Teschke R. RUCAM in Drug and Herb Induced Liver Injury: The Update. Int J Mol Sci. 2015;17:14. [PMID: 26712744 DOI: 10.3390/ijms17010014] [Cited by in Crossref: 256] [Cited by in F6Publishing: 199] [Article Influence: 42.7] [Reference Citation Analysis]
147 Abbing-Karahagopian V, Kurz X, de Vries F, van Staa TP, Alvarez Y, Hesse U, Hasford J, Dijk Lv, de Abajo FJ, Weil JG, Grimaldi-Bensouda L, Egberts AC, Reynolds RF, Klungel OH. Bridging differences in outcomes of pharmacoepidemiological studies: design and first results of the PROTECT project. Curr Clin Pharmacol 2014;9:130-8. [PMID: 24218995 DOI: 10.2174/1574884708666131111211802] [Cited by in Crossref: 42] [Cited by in F6Publishing: 35] [Article Influence: 6.0] [Reference Citation Analysis]
148 Björnsson E, Olsson R. Outcome and prognostic markers in severe drug-induced liver disease. Hepatology. 2005;42:481-489. [PMID: 16025496 DOI: 10.1002/hep.20800] [Cited by in Crossref: 393] [Cited by in F6Publishing: 324] [Article Influence: 24.6] [Reference Citation Analysis]
149 Hoofnagle JH, Navarro VJ. Drug-induced liver injury: Icelandic lessons. Gastroenterology 2013;144:1335-6. [PMID: 23623967 DOI: 10.1053/j.gastro.2013.04.026] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
150 Rigato I, Cravatari M, Avellini C, Ponte E, Crocè SL, Tiribelli C. Drug-induced acute cholestatic liver damage in a patient with mutation of UGT1A1. Nat Clin Pract Gastroenterol Hepatol 2007;4:403-8. [PMID: 17607296 DOI: 10.1038/ncpgasthep0871] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
151 Teschke R. Top-ranking drugs out of 3312 drug-induced liver injury cases evaluated by the Roussel Uclaf Causality Assessment Method.Expert Opin Drug Metab Toxicol. 2018;14:1169-1187. [PMID: 30354694 DOI: 10.1080/17425255.2018.1539077] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
152 Chijioke O, Bawohl M, Springer E, Weber A. Hepatitis e virus detection in liver tissue from patients with suspected drug-induced liver injury. Front Med (Lausanne) 2015;2:20. [PMID: 25870858 DOI: 10.3389/fmed.2015.00020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
153 Teschke R, Schwarzenboeck A, Frenzel C, Schulze J, Eickhoff A, Wolff A. The mystery of the Hawaii liver disease cluster in summer 2013: A pragmatic and clinical approach to solve the problem. Ann Hepatol 2016;15:91-109. [PMID: 26626645 DOI: 10.5604/16652681.1184237] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 5.4] [Reference Citation Analysis]
154 Walker SL, Kennedy F, Niamh N, McCormick PA. Nimesulide associated fulminant hepatic failure. Pharmacoepidemiol Drug Saf. 2008;17:1108-1112. [PMID: 18821716 DOI: 10.1002/pds.1665] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
155 Björnsson E, Kalaitzakis E, Olsson R. The impact of eosinophilia and hepatic necrosis on prognosis in patients with drug-induced liver injury: EOSINOPHILIA IN DRUG-INDUCED LIVER INJURY. Alimentary Pharmacology & Therapeutics 2007;25:1411-21. [DOI: 10.1111/j.1365-2036.2007.03330.x] [Cited by in Crossref: 98] [Cited by in F6Publishing: 81] [Article Influence: 7.0] [Reference Citation Analysis]
156 Grewal P, Ahmad J. Severe liver injury due to herbal and dietary supplements and the role of liver transplantation. World J Gastroenterol 2019;25:6704-12. [PMID: 31857773 DOI: 10.3748/wjg.v25.i46.6704] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 5] [Article Influence: 9.0] [Reference Citation Analysis]
157 Yip VLM, Alfirevic A, Pirmohamed M. Genetics of Immune-Mediated Adverse Drug Reactions: a Comprehensive and Clinical Review. Clinic Rev Allerg Immunol 2015;48:165-75. [DOI: 10.1007/s12016-014-8418-y] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 6.4] [Reference Citation Analysis]
158 Kleiner DE. Recent Advances in the Histopathology of Drug-Induced Liver Injury. Surg Pathol Clin. 2018;11:297-311. [PMID: 29751876 DOI: 10.1016/j.path.2018.02.009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
159 Velayudham LS, Farrell GC. Drug-induced cholestasis. Expert Opin Drug Saf. 2003;2:287-304. [PMID: 12904107 DOI: 10.1517/14740338.2.3.287] [Cited by in Crossref: 60] [Cited by in F6Publishing: 39] [Article Influence: 3.3] [Reference Citation Analysis]
160 Serranti D, Montagnani C, Indolfi G, Chiappini E, Galli L, de Martino M. Antibiotic induced liver injury: what about children? J Chemother 2013;25:255-72. [PMID: 24070133 DOI: 10.1179/1973947813Y.0000000090] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 1.1] [Reference Citation Analysis]
161 Park JH, Hong S, Jun DW, Yoon JH, Lee KN, Lee HL, Lee OY, Yoon BC, Choi HS. Prevalence and clinical characteristics of antibiotics associated drug induced liver injury. Ann Transl Med 2021;9:642. [PMID: 33987340 DOI: 10.21037/atm-20-5144] [Reference Citation Analysis]
162 Sebode M, Schulz L, Lohse AW. "Autoimmune(-Like)" Drug and Herb Induced Liver Injury: New Insights into Molecular Pathogenesis. Int J Mol Sci 2017;18:E1954. [PMID: 28895915 DOI: 10.3390/ijms18091954] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
163 Schiano TD. Hepatotoxicity and complementary and alternative medicines. Clin Liver Dis 2003;7:453-73. [PMID: 12879994 DOI: 10.1016/s1089-3261(03)00030-8] [Cited by in Crossref: 42] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
164 Kim SH, Naisbitt DJ. Update on Advances in Research on Idiosyncratic Drug-Induced Liver Injury. Allergy Asthma Immunol Res. 2016;8:3-11. [PMID: 26540496 DOI: 10.4168/aair.2016.8.1.3] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 5.7] [Reference Citation Analysis]
165 Wendon J, Cordoba J, Dhawan A, Larsen FS, Manns M, Nevens F, Samuel D, Simpson KJ, Yaron I, Bernardi M. EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure. Journal of Hepatology 2017;66:1047-81. [DOI: 10.1016/j.jhep.2016.12.003] [Cited by in Crossref: 280] [Cited by in F6Publishing: 201] [Article Influence: 70.0] [Reference Citation Analysis]
166 Kim SY, Kim BH, Dong SH, Kim HJ, Chang YW, Chang R, Kim YW. Alfuzosin-induced acute liver injury. Korean J Hepatol 2007;13:414-8. [PMID: 17898558 DOI: 10.3350/kjhep.2007.13.3.414] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
167 Teschke R, Frenzel C. Drug induced liver injury: do we still need a routine liver biopsy for diagnosis today? Annals of Hepatology 2014;13:121-6. [DOI: 10.1016/s1665-2681(19)30913-5] [Cited by in Crossref: 18] [Article Influence: 2.6] [Reference Citation Analysis]
168 Viskin S, Havakuk O, Schwaber MJ. Pro-Arrhythmic Effects of Noncardiac Medications. Journal of the American College of Cardiology 2015;66:2185-8. [DOI: 10.1016/j.jacc.2015.09.027] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
169 Saini N, Bakshi S, Sharma S. In-silico approach for drug induced liver injury prediction: Recent advances. Toxicol Lett 2018;295:288-95. [PMID: 29981923 DOI: 10.1016/j.toxlet.2018.06.1216] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 4.3] [Reference Citation Analysis]
170 Ke L, Lu C, Shen R, Lu T, Ma B, Hua Y. Knowledge Mapping of Drug-Induced Liver Injury: A Scientometric Investigation (2010-2019). Front Pharmacol 2020;11:842. [PMID: 32581801 DOI: 10.3389/fphar.2020.00842] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 12.0] [Reference Citation Analysis]
171 Andrade RJ, Lucena MI. Drug Induced Liver Disease: Mechanisms and Diagnosis. In: Mcdonald JW, Burroughs AK, Feagan BG, Fennerty MB, editors. Evidence‐Based Gastroenterology and Hepatology. Wiley; 2010. pp. 771-86. [DOI: 10.1002/9781444314403.ch47] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
172 Kong X, Guo D, Liu S, Zhu Y, Yu C. Incidence, characteristics and risk factors for drug-induced liver injury in hospitalized patients: A matched case-control study. Br J Clin Pharmacol 2021. [PMID: 33948989 DOI: 10.1111/bcp.14847] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
173 López-Riera M, Conde I, Castell JV, Jover R. A Novel MicroRNA Signature for Cholestatic Drugs in Human Hepatocytes and Its Translation into Novel Circulating Biomarkers for Drug-Induced Liver Injury Patients. Toxicol Sci 2020;173:229-43. [PMID: 31198949 DOI: 10.1093/toxsci/kfz138] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
174 Hita EO, García JA, Gonzalez JC, Molina AA, Cordero MA, Escobar JS, Ruiz-Extremera A. Amoxicillin-clavulanic acid hepatotoxicity in children. J Pediatr Gastroenterol Nutr 2012;55:663-7. [PMID: 22710999 DOI: 10.1097/MPG.0b013e318263ebfa] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
175 Andrade RJ, Lucena MI, Fernández MC, Pelaez G, Pachkoria K, García-Ruiz E, García-Muñoz B, González-Grande R, Pizarro A, Durán JA, Jiménez M, Rodrigo L, Romero-Gomez M, Navarro JM, Planas R, Costa J, Borras A, Soler A, Salmerón J, Martin-Vivaldi R; Spanish Group for the Study of Drug-Induced Liver Disease. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology 2005;129:512-21. [PMID: 16083708 DOI: 10.1016/j.gastro.2005.05.006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
176 Teschke R, Danan G. Drug-induced liver injury: Is chronic liver disease a risk factor and a clinical issue? Expert Opin Drug Metab Toxicol. 2017;13:425-438. [PMID: 27822971 DOI: 10.1080/17425255.2017.1252749] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 6.4] [Reference Citation Analysis]
177 Tan EH, Low EXS, Dan YY, Tai BC. Systematic review and meta-analysis of algorithms used to identify drug-induced liver injury (DILI) in health record databases. Liver Int 2018;38:742-53. [PMID: 29193566 DOI: 10.1111/liv.13646] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
178 Zheng EX, Navarro VJ. Liver Injury from Herbal, Dietary, and Weight Loss Supplements: a Review. J Clin Transl Hepatol. 2015;3:93-98. [PMID: 26357638 DOI: 10.14218/jcth.2015.00006] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
179 Cardenas V, Mankuzhy N, Mody R, McCaffery H, Fontana RJ, DiPaola F. Incidence and Sequelae of Liver Injury Among Children Treated for Solid Tumors: Analysis of a Large Single-Center Prospective Cohort. J Pediatr Gastroenterol Nutr 2020;71:197-202. [PMID: 32404749 DOI: 10.1097/MPG.0000000000002767] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
180 Wai CT, Tan BH, Chan CL, Sutedja DS, Lee YM, Khor C, Lim SG. Drug-induced liver injury at an Asian center: a prospective study. Liver Int 2007;27:465-74. [PMID: 17403186 DOI: 10.1111/j.1478-3231.2007.01461.x] [Cited by in Crossref: 99] [Cited by in F6Publishing: 75] [Article Influence: 7.1] [Reference Citation Analysis]
181 Heslop JA, Kia R, Pridgeon CS, Sison-Young RL, Liloglou T, Elmasry M, Fenwick SW, Mills JS, Kitteringham NR, Goldring CE, Park BK. Donor-Dependent and Other Nondefined Factors Have Greater Influence on the Hepatic Phenotype Than the Starting Cell Type in Induced Pluripotent Stem Cell Derived Hepatocyte-Like Cells. Stem Cells Transl Med 2017;6:1321-31. [PMID: 28456008 DOI: 10.1002/sctm.16-0029] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
182 Meunier L, Larrey D. Drug-Induced Liver Injury: Biomarkers, Requirements, Candidates, and Validation. Front Pharmacol 2019;10:1482. [PMID: 31920666 DOI: 10.3389/fphar.2019.01482] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 9.5] [Reference Citation Analysis]
183 Alfirevic A, Pirmohamed M. Predictive genetic testing for drug-induced liver injury: considerations of clinical utility. Clin Pharmacol Ther 2012;92:376-80. [PMID: 22850601 DOI: 10.1038/clpt.2012.107] [Cited by in Crossref: 41] [Cited by in F6Publishing: 30] [Article Influence: 4.6] [Reference Citation Analysis]
184 Ruan J, Gao H, Li N, Xue J, Chen J, Ke C, Ye Y, Fu PP, Zheng J, Wang J, Lin G. Blood Pyrrole-Protein Adducts--A Biomarker of Pyrrolizidine Alkaloid-Induced Liver Injury in Humans. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 2015;33:404-21. [PMID: 26398275 DOI: 10.1080/10590501.2015.1096882] [Cited by in Crossref: 48] [Cited by in F6Publishing: 38] [Article Influence: 9.6] [Reference Citation Analysis]
185 Hou F, Zeng Z, Wang G. Hospital Admissions for Drug-Induced Liver Injury: Clinical Features, Therapy, and Outcomes. Cell Biochem Biophys 2012;64:77-83. [DOI: 10.1007/s12013-012-9373-y] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
186 Yusuf D, Christy J, Owen D, Ho M, Li D, Fishman MJ. A case report of nifedipine-induced hepatitis with jaundice. BMC Res Notes. 2018;11:228. [PMID: 29615102 DOI: 10.1186/s13104-018-3322-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
187 Jinjuvadia K, Kwan W, Fontana RJ. Searching for a needle in a haystack: use of ICD-9-CM codes in drug-induced liver injury. Am J Gastroenterol 2007;102:2437-43. [PMID: 17662100 DOI: 10.1111/j.1572-0241.2007.01456.x] [Cited by in Crossref: 54] [Cited by in F6Publishing: 42] [Article Influence: 3.9] [Reference Citation Analysis]
188 Idilman R, Bektas M, Cinar K, Toruner M, Cerit ET, Doganay B, Erden E, Bozkaya H, Bahar K, Karayalcin S, Soykan I, Palabiyikoglu M, Cetinkaya H, Yurdaydin C, Dokmeci A, Ozden A. The characteristics and clinical outcome of drug-induced liver injury: a single-center experience. J Clin Gastroenterol 2010;44:e128-32. [PMID: 20551776 DOI: 10.1097/MCG.0b013e3181c5e9cc] [Cited by in Crossref: 25] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
189 DiPaola F, Molleston JP, Gu J, Cirulli ET, Chalasani N, Barnhart H, Kleiner DE, Hoofnagle JH, Fontana RJ; US Drug Induced Liver Injury Network. Antimicrobials and Antiepileptics Are the Leading Causes of Idiosyncratic Drug-induced Liver Injury in American Children. J Pediatr Gastroenterol Nutr 2019;69:152-9. [PMID: 31169665 DOI: 10.1097/MPG.0000000000002383] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
190 Daly AK, Day CP. Genetic association studies in drug-induced liver injury. Drug Metab Rev. 2012;44:116-126. [PMID: 21913872 DOI: 10.3109/03602532.2011.605790] [Cited by in Crossref: 71] [Cited by in F6Publishing: 56] [Article Influence: 7.1] [Reference Citation Analysis]
191 Lea JD, Clarke JI, McGuire N, Antoine DJ. Redox-Dependent HMGB1 Isoforms as Pivotal Co-Ordinators of Drug-Induced Liver Injury: Mechanistic Biomarkers and Therapeutic Targets. Antioxid Redox Signal 2016;24:652-65. [PMID: 26481429 DOI: 10.1089/ars.2015.6406] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
192 Chen M, Vijay V, Shi Q, Liu Z, Fang H, Tong W. FDA-approved drug labeling for the study of drug-induced liver injury. Drug Discov Today. 2011;16:697-703. [PMID: 21624500 DOI: 10.1016/j.drudis.2011.05.007] [Cited by in Crossref: 245] [Cited by in F6Publishing: 193] [Article Influence: 24.5] [Reference Citation Analysis]
193 Russo MW, Steuerwald N, Norton HJ, Anderson WE, Foureau D, Chalasani N, Fontana RJ, Watkins PB, Serrano J, Bonkovsky HL. Profiles of miRNAs in serum in severe acute drug induced liver injury and their prognostic significance. Liver Int. 2016; Epub ahead of print. [PMID: 27860186 DOI: 10.1111/liv.13312] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 5.6] [Reference Citation Analysis]
194 Benesic A, Leitl A, Gerbes AL. Monocyte-derived hepatocyte-like cells for causality assessment of idiosyncratic drug-induced liver injury. Gut 2016;65:1555-63. [PMID: 26045135 DOI: 10.1136/gutjnl-2015-309528] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
195 Mueller EW, Rockey ML, Rashkin MC. Sunitinib-Related Fulminant Hepatic Failure: Case Report and Review of the Literature. Pharmacotherapy 2008;28:1066-70. [DOI: 10.1592/phco.28.8.1066] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 2.8] [Reference Citation Analysis]
196 Amin MD, Harpavat S, Leung DH. Drug-induced liver injury in children. Current Opinion in Pediatrics 2015;27:625-33. [DOI: 10.1097/mop.0000000000000264] [Cited by in Crossref: 14] [Cited by in F6Publishing: 1] [Article Influence: 2.3] [Reference Citation Analysis]
197 Bhamidimarri KR, Schiff E. Drug-induced cholestasis. Clin Liver Dis. 2013;17:519-531, vii. [PMID: 24099015 DOI: 10.1016/j.cld.2013.07.015] [Cited by in Crossref: 44] [Cited by in F6Publishing: 25] [Article Influence: 6.3] [Reference Citation Analysis]
198 Assis DN, Navarro VJ. Human drug hepatotoxicity: a contemporary clinical perspective. Expert Opin Drug Metab Toxicol 2009;5:463-73. [PMID: 19416083 DOI: 10.1517/17425250902927386] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 2.9] [Reference Citation Analysis]
199 Verma A, Lilienfeld DE. The need for a population-based surveillance system for liver disease in the United States. Pharmacoepidemiol Drug Saf 2004;13:821-4. [PMID: 15486959 DOI: 10.1002/pds.1022] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
200 García-Cortés M, Lucena MI, Pachkoria K, Borraz Y, Hidalgo R, Andrade RJ. Evaluation of naranjo adverse drug reactions probability scale in causality assessment of drug-induced liver injury. Aliment Pharmacol Ther. 2008;27:780-789. [PMID: 18284654 DOI: 10.1111/j.1365-2036.2008.03655.x] [Cited by in Crossref: 103] [Cited by in F6Publishing: 89] [Article Influence: 7.9] [Reference Citation Analysis]
201 Ortega-Alonso A, Stephens C, Lucena MI, Andrade RJ. Case Characterization, Clinical Features and Risk Factors in Drug-Induced Liver Injury. Int J Mol Sci. 2016;17. [PMID: 27187363 DOI: 10.3390/ijms17050714] [Cited by in Crossref: 38] [Cited by in F6Publishing: 29] [Article Influence: 7.6] [Reference Citation Analysis]
202 Pais R, Rusu E, Ratziu V. The impact of obesity and metabolic syndrome on chronic hepatitis B and drug-induced liver disease. Clin Liver Dis. 2014;18:165-178. [PMID: 24274872 DOI: 10.1016/j.cld.2013.09.015] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
203 Metushi IG, Cai P, Vega L, Grant DM, Uetrecht J. Paradoxical Attenuation of Autoimmune Hepatitis by Oral Isoniazid in Wild-Type and N -Acetyltransferase–Deficient Mice. Drug Metab Dispos 2014;42:963-73. [DOI: 10.1124/dmd.113.056622] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
204 Isabel Lucena M, García-cortés M, Cueto R, Lopez-duran J, Andrade RJ. Assessment of drug-induced liver injury in clinical practice. Fundam Clin Pharmacol 2008;22:141-58. [DOI: 10.1111/j.1472-8206.2008.00566.x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 39] [Article Influence: 3.8] [Reference Citation Analysis]
205 Kowalec K, Kingwell E, Yoshida EM, Marrie RA, Kremenchutzky M, Campbell TL, Wadelius M, Carleton B, Tremlett H. Characteristics associated with drug-induced liver injury from interferon beta in multiple sclerosis patients. Expert Opinion on Drug Safety 2014;13:1305-17. [DOI: 10.1517/14740338.2014.947958] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
206 Ghatalia P, Je Y, Mouallem NE, Nguyen PL, Trinh QD, Sonpavde G, Choueiri TK. Hepatotoxicity with vascular endothelial growth factor receptor tyrosine kinase inhibitors: A meta-analysis of randomized clinical trials. Crit Rev Oncol Hematol 2015;93:257-76. [PMID: 25523486 DOI: 10.1016/j.critrevonc.2014.11.006] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
207 Boelsterli UA, Lim PL. Mitochondrial abnormalities--a link to idiosyncratic drug hepatotoxicity? Toxicol Appl Pharmacol 2007;220:92-107. [PMID: 17275868 DOI: 10.1016/j.taap.2006.12.013] [Cited by in Crossref: 165] [Cited by in F6Publishing: 134] [Article Influence: 11.0] [Reference Citation Analysis]
208 Rossi S, Navarro VJ. Herbs and liver injury: a clinical perspective. Clin Gastroenterol Hepatol. 2014;12:1069-1076. [PMID: 23924877 DOI: 10.1016/j.cgh.2013.07.030] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
209 Hanatani T, Sai K, Tohkin M, Segawa K, Kimura M, Hori K, Kawakami J, Saito Y. A detection algorithm for drug-induced liver injury in medical information databases using the Japanese diagnostic scale and its comparison with the Council for International Organizations of Medical Sciences/the Roussel Uclaf Causality Assessment Method scale. Pharmacoepidemiol Drug Saf. 2014;23:984-988. [PMID: 24596340 DOI: 10.1002/pds.3603] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.9] [Reference Citation Analysis]
210 Donati M, Conforti A, Lenti MC, Capuano A, Bortolami O, Motola D, Moretti U, Vannacci A, Rafaniello C, Vaccheri A, Arzenton E, Bonaiuti R, Sportiello L, Leone R; DILI-IT Study Group. Risk of acute and serious liver injury associated to nimesulide and other NSAIDs: data from drug-induced liver injury case-control study in Italy. Br J Clin Pharmacol 2016;82:238-48. [PMID: 26991794 DOI: 10.1111/bcp.12938] [Cited by in Crossref: 32] [Cited by in F6Publishing: 20] [Article Influence: 6.4] [Reference Citation Analysis]
211 Soleimanpour M, Imani F, Safari S, Sanaie S, Soleimanpour H, Ameli H, Alavian SM. The Role of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in the Treatment of Patients With Hepatic Disease: A Review Article. Anesth Pain Med 2016;6:e37822. [PMID: 27843779 DOI: 10.5812/aapm.37822] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.2] [Reference Citation Analysis]
212 Fontana RJ, Watkins PB, Bonkovsky HL, Chalasani N, Davern T, Serrano J, Rochon J. Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct. Drug Saf. 2009;32:55-68. [PMID: 19132805 DOI: 10.2165/00002018-200932010-00005.] [Reference Citation Analysis]
213 Devarbhavi H. An Update on Drug-induced Liver Injury. J Clin Exp Hepatol. 2012;2:247-259. [PMID: 25755441 DOI: 10.1016/j.jceh.2012.05.002] [Cited by in Crossref: 63] [Cited by in F6Publishing: 40] [Article Influence: 7.0] [Reference Citation Analysis]
214 Licata A. Adverse drug reactions and organ damage: The liver. Eur J Intern Med. 2016;28:9-16. [PMID: 26827101 DOI: 10.1016/j.ejim.2015.12.017] [Cited by in Crossref: 42] [Cited by in F6Publishing: 30] [Article Influence: 8.4] [Reference Citation Analysis]
215 Raschi E, De Ponti F. Drug- and herb-induced liver injury: Progress, current challenges and emerging signals of post-marketing risk. World J Hepatol. 2015;7:1761-1771. [PMID: 26167249 DOI: 10.4254/wjh.v7.i13.1761] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 5.8] [Reference Citation Analysis]
216 Voican CS, Martin S, Verstuyft C, Corruble E, Perlemuter G, Colle R. Liver Function Test Abnormalities in Depressed Patients Treated with Antidepressants: A Real-World Systematic Observational Study in Psychiatric Settings. PLoS One 2016;11:e0155234. [PMID: 27171561 DOI: 10.1371/journal.pone.0155234] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
217 Amathieu R, Levesque E, Merle JC, Chemit M, Costentin C, Compagnon P, Dhonneur G. [Severe toxic acute liver failure: etiology and treatment]. Ann Fr Anesth Reanim. 2013;32:416-421. [PMID: 23683460 DOI: 10.1016/j.annfar.2013.03.004] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
218 Lucena MI, Andrade RJ, Kaplowitz N, García-Cortes M, Fernández MC, Romero-Gomez M, Bruguera M, Hallal H, Robles-Diaz M, Rodriguez-González JF. Phenotypic characterization of idiosyncratic drug-induced liver injury: the influence of age and sex. Hepatology. 2009;49:2001-2009. [PMID: 19475693 DOI: 10.1002/hep.22895] [Cited by in Crossref: 207] [Cited by in F6Publishing: 171] [Article Influence: 17.3] [Reference Citation Analysis]
219 Rotondo E, Graziosi A, Di Stefano V, Mohn AA. Methylprednisolone-induced hepatotoxicity in a 16-year-old girl with multiple sclerosis. BMJ Case Rep 2018;11:e226687. [PMID: 30567201 DOI: 10.1136/bcr-2018-226687] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
220 Aithal GP. Diclofenac-induced liver injury: a paradigm of idiosyncratic drug toxicity. Expert Opin Drug Saf. 2004;3:519-523. [PMID: 15500411 DOI: 10.1517/14740338.3.6.519] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 2.2] [Reference Citation Analysis]
221 Devarbhavi H, Aithal G, Treeprasertsuk S, Takikawa H, Mao Y, Shasthry SM, Hamid S, Tan SS, Philips CA, George J, Jafri W, Sarin SK; Asia Pacific Association of Study of Liver. Drug-induced liver injury: Asia Pacific Association of Study of Liver consensus guidelines. Hepatol Int 2021;15:258-82. [PMID: 33641080 DOI: 10.1007/s12072-021-10144-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
222 Petronijevic M, Ilic K. Associations of gender and age with the reporting of drug-induced hepatic failure: data from the VigiBase™. J Clin Pharmacol. 2013;53:435-443. [PMID: 23440959 DOI: 10.1002/jcph.3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
223 Lewis JH. Drug-Induced Liver Injury Throughout the Drug Development Life Cycle: Where We Have Been, Where We are Now, and Where We are Headed. Perspectives of a Clinical Hepatologist. Pharm Med 2013;27:165-91. [DOI: 10.1007/s40290-013-0015-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 1.9] [Reference Citation Analysis]
224 Liu Y, Li P, Wang F, Liu L, Zhang Y, Liu Y, Shi R. Comparison of diagnostic accuracy of 3 diagnostic criteria combined with refined pathological scoring system for drug-induced liver injury. Medicine (Baltimore) 2020;99:e22259. [PMID: 33031266 DOI: 10.1097/MD.0000000000022259] [Reference Citation Analysis]
225 Marschall H, Wagner M, Zollner G, Trauner M. Clinical Hepatotoxicity. Regulation and Treatment with Inducers of Transport and Cofactors. Mol Pharmaceutics 2007;4:895-910. [DOI: 10.1021/mp060133c] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
226 Laster J, Satoskar R. Aspirin-Induced Acute Liver Injury. ACG Case Rep J 2014;2:48-9. [PMID: 26157904 DOI: 10.14309/crj.2014.81] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
227 Imam Z, Khasawneh M, Jomaa D, Iftikhar H, Sayedahmad Z. Drug Induced Liver Injury Attributed to a Curcumin Supplement. Case Rep Gastrointest Med. 2019;2019:6029403. [PMID: 31781418 DOI: 10.1155/2019/6029403] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
228 Korolczuk A, Caban K, Amarowicz M, Czechowska G, Irla-Miduch J. Oxidative Stress and Liver Morphology in Experimental Cyclosporine A-Induced Hepatotoxicity. Biomed Res Int 2016;2016:5823271. [PMID: 27298826 DOI: 10.1155/2016/5823271] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 4.2] [Reference Citation Analysis]
229 Amacher DE. The primary role of hepatic metabolism in idiosyncratic drug-induced liver injury. Expert Opinion on Drug Metabolism & Toxicology 2012;8:335-47. [DOI: 10.1517/17425255.2012.658041] [Cited by in Crossref: 42] [Cited by in F6Publishing: 34] [Article Influence: 4.7] [Reference Citation Analysis]
230 Kaye JA, Castellsague J, Bui CL, Calingaert B, McQuay LJ, Riera-Guardia N, Saltus CW, Quinlan S, Holick CN, Wahl PM, Suzart K, Rothman KJ, Wallander MA, Perez-Gutthann S. Risk of acute liver injury associated with the use of moxifloxacin and other oral antimicrobials: a retrospective, population-based cohort study. Pharmacotherapy 2014;34:336-49. [PMID: 24865821 DOI: 10.1002/phar.1367] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
231 Carey EJ, Vargas HE, Douglas DD, Balan V, Byrne TJ, Harrison ME, Rakela J. Inpatient admissions for drug-induced liver injury: results from a single center. Dig Dis Sci. 2008;53:1977-1982. [PMID: 18392678 DOI: 10.1007/s10620-008-0250-x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
232 Pedraza L, Laosa O, Rodríguez-Mañas L, Gutiérrez-Romero DF, Frías J, Carnicero JA, Ramírez E. Drug Induced Liver Injury in Geriatric Patients Detected by a Two-Hospital Prospective Pharmacovigilance Program: A Comprehensive Analysis Using the Roussel Uclaf Causality Assessment Method. Front Pharmacol 2020;11:600255. [PMID: 33613279 DOI: 10.3389/fphar.2020.600255] [Reference Citation Analysis]
233 Nguyen KD, Sundaram V, Ayoub WS. Atypical causes of cholestasis. World J Gastroenterol. 2014;20:9418-9426. [PMID: 25071336 DOI: 10.3748/wjg.v20.i28.9418] [Cited by in F6Publishing: 17] [Reference Citation Analysis]
234 Khoury T, Chen S, Abu Rmeileh A, Daher S, Yaari S, Benson AA, Cohen J, Mizrahi M. Acute liver injury induced by levetiracetam and temozolomide co-treatment. Dig Liver Dis 2017;49:297-300. [PMID: 28034663 DOI: 10.1016/j.dld.2016.11.015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
235 Corsini A, Ganey P, Ju C, Kaplowitz N, Pessayre D, Roth R, Watkins PB, Albassam M, Liu B, Stancic S, Suter L, Bortolini M. Current Challenges and Controversies in Drug-Induced Liver Injury. Drug Saf 2012;35:1099-117. [DOI: 10.1007/bf03261997] [Cited by in Crossref: 44] [Cited by in F6Publishing: 14] [Article Influence: 4.9] [Reference Citation Analysis]
236 Apel K, Pütz K, Tolkach Y, Canbay A, Drebber U. [Drug-induced liver injury-significance of pathology]. Pathologe 2020;41:457-70. [PMID: 32813127 DOI: 10.1007/s00292-020-00811-x] [Reference Citation Analysis]
237 Miyama H, Shiraishi Y, Kohsaka S, Goda A, Nishihata Y, Nagatomo Y, Takei M, Fukuda K, Kohno T, Yoshikawa T. Abnormal Liver Function Tests and Long-Term Outcomes in Patients Discharged after Acute Heart Failure. J Clin Med 2021;10:1730. [PMID: 33923618 DOI: 10.3390/jcm10081730] [Reference Citation Analysis]
238 Moseley RH. Hepatotoxicity of Antimicrobials and Antifungal Agents. Drug-Induced Liver Disease. Elsevier; 2013. pp. 463-81. [DOI: 10.1016/b978-0-12-387817-5.00026-1] [Cited by in Crossref: 6] [Article Influence: 0.8] [Reference Citation Analysis]
239 Lat I, Foster DR, Erstad B. Drug-induced acute liver failure and gastrointestinal complications. Crit Care Med. 2010;38:S175-S187. [PMID: 20502172 DOI: 10.1097/ccm.0b013e3181de0db2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 3] [Article Influence: 1.6] [Reference Citation Analysis]
240 Chen SS, Yu KK, Huang C, Li N, Zheng JM, Bao SX, Chen MQ, Zhang WH. The characteristics and clinical outcome of drug-induced liver injury in a Chinese hospital: A retrospective cohort study. Medicine (Baltimore) 2016;95:e4683. [PMID: 27559976 DOI: 10.1097/MD.0000000000004683] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
241 European Association for the Study of the Liver;  Clinical Practice Guideline Panel: Chair;  Panel members;  EASL Governing Board representative. EASL Clinical Practice Guidelines: Drug-induced liver injury. J Hepatol. 2019;70:1222-1261. [PMID: 30926241 DOI: 10.1016/j.jhep.2019.02.014] [Cited by in Crossref: 198] [Cited by in F6Publishing: 131] [Article Influence: 99.0] [Reference Citation Analysis]
242 Pugh AJ, Barve AJ, Falkner K, Patel M, McClain CJ. Drug-induced hepatotoxicity or drug-induced liver injury. Clin Liver Dis 2009;13:277-94. [PMID: 19442919 DOI: 10.1016/j.cld.2009.02.008] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
243 Agúndez JA, Lucena MI, Martínez C, Andrade RJ, Blanca M, Ayuso P, García-Martín E. Assessment of nonsteroidal anti-inflammatory drug-induced hepatotoxicity. Expert Opin Drug Metab Toxicol. 2011;7:817-828. [PMID: 21473713 DOI: 10.1517/17425255.2011.574613] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 3.2] [Reference Citation Analysis]
244 Liu Y, Zhan SP, Song L, Chen Y, Jia YT, Liu F, Sun FJ, Wang Q, Xia PY. Drug-Induced Liver Injury: Clinical and Etiologic Features at a Large Tertiary Teaching Hospital in China. Med Sci Monit 2020;26:e919435. [PMID: 32172275 DOI: 10.12659/MSM.919435] [Reference Citation Analysis]
245 Cano-paniagua A, Amariles P, Angulo N, Restrepo-garay M. Epidemiology of drug-induced liver injury in a University Hospital from Colombia: Updated RUCAM being used for prospective causality assessment. Annals of Hepatology 2019;18:501-7. [DOI: 10.1016/j.aohep.2018.11.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
246 Unzueta A, Vargas HE. Nonsteroidal anti-inflammatory drug-induced hepatoxicity. Clin Liver Dis 2013;17:643-56, ix. [PMID: 24099022 DOI: 10.1016/j.cld.2013.07.009] [Cited by in Crossref: 34] [Cited by in F6Publishing: 20] [Article Influence: 4.3] [Reference Citation Analysis]
247 De Valle MB, Av Klinteberg V, Alem N, Olsson R, Björnsson E. Drug-induced liver injury in a Swedish University hospital out-patient hepatology clinic. Aliment Pharmacol Ther. 2006;24:1187-1195. [PMID: 17014577 DOI: 10.1111/j.1365-2036.2006.03117.x] [Cited by in Crossref: 136] [Cited by in F6Publishing: 122] [Article Influence: 9.7] [Reference Citation Analysis]
248 Ezhilarasan D, Raghunandhakumar S. Boldine treatment protects acetaminophen-induced liver inflammation and acute hepatic necrosis in mice. J Biochem Mol Toxicol 2021;35:e22697. [PMID: 33393705 DOI: 10.1002/jbt.22697] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
249 Hillman L, Gottfried M, Whitsett M, Rakela J, Schilsky M, Lee WM, Ganger D. Clinical Features and Outcomes of Complementary and Alternative Medicine Induced Acute Liver Failure and Injury. Am J Gastroenterol. 2016;111:958-965. [PMID: 27045922 DOI: 10.1038/ajg.2016.114] [Cited by in Crossref: 60] [Cited by in F6Publishing: 43] [Article Influence: 12.0] [Reference Citation Analysis]
250 Allard J, Le Guillou D, Begriche K, Fromenty B. Drug-induced liver injury in obesity and nonalcoholic fatty liver disease. Adv Pharmacol 2019;85:75-107. [PMID: 31307592 DOI: 10.1016/bs.apha.2019.01.003] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 11.0] [Reference Citation Analysis]
251 Mrzljak A, Kosuta I, Skrtic A, Kanizaj TF, Vrhovac R. Drug-Induced Liver Injury Associated with Noni (Morinda citrifolia) Juice and Phenobarbital. Case Rep Gastroenterol. 2013;7:19-24. [PMID: 23467452 DOI: 10.1159/000343651] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
252 Chayanupatkul M, Schiano TD. Acute Liver Failure Secondary to Drug-Induced Liver Injury. Clin Liver Dis 2020;24:75-87. [PMID: 31753252 DOI: 10.1016/j.cld.2019.09.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
253 Björnsson ES, Bergmann OM, Björnsson HK, Kvaran RB, Olafsson S. Incidence, Presentation, and Outcomes in Patients With Drug-Induced Liver Injury in the General Population of Iceland. Gastroenterology 2013;144:1419-1425.e3. [DOI: 10.1053/j.gastro.2013.02.006] [Cited by in Crossref: 436] [Cited by in F6Publishing: 343] [Article Influence: 54.5] [Reference Citation Analysis]
254 Jaiprakash H, Narayana S, Mohanraj J. Drug-induced hepatotoxicity in a tertiary care hospital in rural South India. N Am J Med Sci 2012;4:90-3. [PMID: 22408755 DOI: 10.4103/1947-2714.93385] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
255 Liu Y, Li P, Liu L, Zhang Y. The diagnostic role of miR-122 in drug-induced liver injury: A systematic review and meta-analysis. Medicine (Baltimore) 2018;97:e13478. [PMID: 30544438 DOI: 10.1097/MD.0000000000013478] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
256 Udo R, Maitland-van der Zee AH, Egberts TC, den Breeijen JH, Leufkens HG, van Solinge WW, De Bruin ML. Validity of diagnostic codes and laboratory measurements to identify patients with idiopathic acute liver injury in a hospital database. Pharmacoepidemiol Drug Saf 2016;25 Suppl 1:21-8. [PMID: 26147715 DOI: 10.1002/pds.3824] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
257 Fontana RJ, Hayashi PH, Gu J, Reddy KR, Barnhart H, Watkins PB, Serrano J, Lee WM, Chalasani N, Stolz A, Davern T, Talwakar JA; DILIN Network. Idiosyncratic drug-induced liver injury is associated with substantial morbidity and mortality within 6 months from onset. Gastroenterology 2014;147:96-108.e4. [PMID: 24681128 DOI: 10.1053/j.gastro.2014.03.045] [Cited by in Crossref: 128] [Cited by in F6Publishing: 98] [Article Influence: 18.3] [Reference Citation Analysis]
258 Fontana RJ, Watkins PB, Bonkovsky HL, Chalasani N, Davern T, Serrano J, Rochon J. Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct. Drug Saf. 2009;32:55-68. [PMID: 19132805 DOI: 10.2165/00002018-200932010-00005] [Cited by in Crossref: 286] [Cited by in F6Publishing: 239] [Article Influence: 23.8] [Reference Citation Analysis]
259 Lucena MI, Cohen H, Hernández N, Bessone F, Dacoll C, Stephens C, Borraz Y, Ulzurrun E, Bruguera M, Andrade RJ. Hepatotoxicidad, un problema global con especificidades locales: hacia la creación de una Red Hispano Latinoamericana de Hepatotoxicidad. Gastroenterología y Hepatología 2011;34:361-8. [DOI: 10.1016/j.gastrohep.2011.01.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
260 Lucena MI, Molokhia M, Shen Y, Urban TJ, Aithal GP, Andrade RJ, Day CP, Ruiz-Cabello F, Donaldson PT, Stephens C, Pirmohamed M, Romero-Gomez M, Navarro JM, Fontana RJ, Miller M, Groome M, Bondon-Guitton E, Conforti A, Stricker BH, Carvajal A, Ibanez L, Yue QY, Eichelbaum M, Floratos A, Pe'er I, Daly MJ, Goldstein DB, Dillon JF, Nelson MR, Watkins PB, Daly AK; Spanish DILI Registry; EUDRAGENE; DILIN; DILIGEN; International SAEC. Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles. Gastroenterology. 2011;141:338-347. [PMID: 21570397 DOI: 10.1053/j.gastro.2011.04.001] [Cited by in Crossref: 312] [Cited by in F6Publishing: 242] [Article Influence: 31.2] [Reference Citation Analysis]
261 Lacroix I, Lapeyre-mestre M, Bagheri H, Pathak A, Montastruc J; the Club de Reflexion des cabinets de Groupe de Gastro-Enterologie (CREGG) and General Practitioner Networks. Nonsteroidal anti-inflammatory drug-induced liver injury: a case-control study in primary care. Fundam Clin Pharmacol 2004;18:201-6. [DOI: 10.1111/j.1472-8206.2004.00224.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
262 Teschke R, Eickhoff A. Herbal hepatotoxicity in traditional and modern medicine: actual key issues and new encouraging steps. Front Pharmacol. 2015;6:72. [PMID: 25954198 DOI: 10.3389/fphar.2015.00072] [Cited by in Crossref: 75] [Cited by in F6Publishing: 67] [Article Influence: 12.5] [Reference Citation Analysis]
263 Donnez J, Arriagada P, Marciniak M, Larrey D. Liver safety parameters of ulipristal acetate for the treatment of uterine fibroids: a comprehensive review of the clinical development program. Expert Opin Drug Saf 2018;17:1225-32. [PMID: 30460871 DOI: 10.1080/14740338.2018.1550070] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 11.3] [Reference Citation Analysis]
264 Devarbhavi H, Joseph T, Sunil Kumar N, Rathi C, Thomas V, Prasad Singh S, Sawant P, Goel A, Eapen CE, Rai P, Arora A, Leelakrishnan V, Gopalakrishnan G, Vardhan Reddy V, Singh R, Goswami B, Venkataraman J, Balaraju G, Patil M, Patel R, Taneja S, Koshy A, Nagaraja Rao P, Kumar Sarin S, Rathi P, Dhiman R, Duseja AK, Vargese J, Kumar Jain A, Wadhawan M, Ranjan P, Karanth D, Ganesh P, Nijhawan S, Krishna Dhali G, Adarsh CK, Jhaveri A, Nagral A, Rao P, Shalimar. The Indian Network of Drug-Induced Liver Injury: Etiology, Clinical Features, Outcome and Prognostic Markers in 1288 Patients. J Clin Exp Hepatol 2021;11:288-98. [PMID: 33994711 DOI: 10.1016/j.jceh.2020.11.002] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
265 Wohlreich MM, Acharya N, Strombom I, Kuritzky L, Robinson M, Heinloth AN, Regev A, Wernicke JF. Answers to the Most Common Questions About the Hepatic Safety Profile of Duloxetine. Postgraduate Medicine 2015;120:111-8. [DOI: 10.3810/pgm.2008.07.1803] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
266 Tajiri K, Shimizu Y. Practical guidelines for diagnosis and early management of drug-induced liver injury. World J Gastroenterol. 2008;14:6774-6785. [PMID: 19058303 DOI: 10.3748/wig.14.6774] [Reference Citation Analysis]
267 Lauschke VM. Toxicogenomics of drug induced liver injury - from mechanistic understanding to early prediction. Drug Metab Rev 2021;53:245-52. [PMID: 33683927 DOI: 10.1080/03602532.2021.1894571] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
268 Becker MW, Schwambach KH, Lunardelli M, Blatt CR. Overview of drug induced liver injury in Brazil: What is the role of public health policy on the evidence? World J Gastrointest Pharmacol Ther 2021;12:40-55. [PMID: 34046243 DOI: 10.4292/wjgpt.v12.i3.40] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
269 Andrade RJ, Ortega-Alonso A, Lucena MI. “Drug-Induced Liver Injury Clinical Consortia: a global research response for a worldwide health challenge”. Expert Opin Drug Metab Toxicol. 2016;12:589-593. [PMID: 26820043 DOI: 10.1517/17425255.2016.1141896] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
270 Lee J, Shin J, Lee YJ, Kim M, Shin B, Lee J, Lee MS, Ha I. Battle Over Herb-Induced Liver Injury: Low Prevalence Confirmed through Secondary Evaluation and Research Team's Clarifying Rebuttal to Unwarranted Public Claims. The Journal of Alternative and Complementary Medicine 2019;25:260-4. [DOI: 10.1089/acm.2018.0253] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
271 Novak D, Lewis JH. Drug-induced liver disease: . Current Opinion in Gastroenterology 2003;19:203-15. [DOI: 10.1097/00001574-200305000-00004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
272 Invernizzi P. Drug-induced liver injury: is it time for genetics to change our clinical practice? J Hepatol 2010;53:993-4. [PMID: 20851491 DOI: 10.1016/j.jhep.2010.08.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
273 Nanau RM, Neuman MG. Ibuprofen-induced hypersensitivity syndrome. Translational Research 2010;155:275-93. [DOI: 10.1016/j.trsl.2010.01.005] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
274 Björnsson ES. Drug-induced liver injury due to antibiotics. Scand J Gastroenterol 2017;52:617-23. [PMID: 28276834 DOI: 10.1080/00365521.2017.1291719] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 6.5] [Reference Citation Analysis]
275 Kang Y, Kim SH, Park SY, Park BY, Lee JH, An J, Won HK, Song WJ, Kwon HS, Cho YS, Moon HB, Shim JH, Yang MS, Kim TB. Evaluation of Drug-Induced Liver Injury Developed During Hospitalization Using Electronic Health Record (EHR)-Based Algorithm. Allergy Asthma Immunol Res 2020;12:430-42. [PMID: 32141257 DOI: 10.4168/aair.2020.12.3.430] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
276 Gao Y, Cao Z, Yang X, Abdelmegeed MA, Sun J, Chen S, Beger RD, Davis K, Salminen WF, Song BJ, Mendrick DL, Yu LR. Proteomic analysis of acetaminophen-induced hepatotoxicity and identification of heme oxygenase 1 as a potential plasma biomarker of liver injury. Proteomics Clin Appl 2017;11. [PMID: 27634590 DOI: 10.1002/prca.201600123] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 3.2] [Reference Citation Analysis]
277 Park HK, Jo W, Choi HJ, Jang S, Ryu JE, Lee HJ, Lee H, Kim H, Yu ES, Son WC. Time-course changes in the expression levels of miR-122, -155, and -21 as markers of liver cell damage, inflammation, and regeneration in acetaminophen-induced liver injury in rats. J Vet Sci 2016;17:45-51. [PMID: 27051339 DOI: 10.4142/jvs.2016.17.1.45] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 4.6] [Reference Citation Analysis]
278 Björnsson ES. Incidence and outcomes of DILI in Western patients. Clin Liver Dis (Hoboken) 2014;4:9-11. [PMID: 30992911 DOI: 10.1002/cld.368] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
279 Fontana RJ. Pathogenesis of idiosyncratic drug-induced liver injury and clinical perspectives. Gastroenterology. 2014;146:914-928. [PMID: 24389305 DOI: 10.1053/j.gastro.2013.12.032] [Cited by in Crossref: 147] [Cited by in F6Publishing: 112] [Article Influence: 18.4] [Reference Citation Analysis]
280 Ogiso T, Fukami T, Mishiro K, Konishi K, Jones JP, Nakajima M. Substrate selectivity of human aldehyde oxidase 1 in reduction of nitroaromatic drugs. Archives of Biochemistry and Biophysics 2018;659:85-92. [DOI: 10.1016/j.abb.2018.10.017] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
281 Ferrajolo C, Verhamme KM, Trifirò G, ‘t Jong GW, Giaquinto C, Picelli G, Oteri A, de Bie S, Valkhoff VE, Schuemie MJ. Idiopathic acute liver injury in paediatric outpatients: incidence and signal detection in two European countries. Drug Saf. 2013;36:1007-1016. [PMID: 23591830 DOI: 10.1007/s40264-013-0045-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
282 Khoury T, Rmeileh AA, Yosha L, Benson AA, Daher S, Mizrahi M. Drug Induced Liver Injury: Review with a Focus on Genetic Factors, Tissue Diagnosis, and Treatment Options. J Clin Transl Hepatol 2015;3:99-108. [PMID: 26356634 DOI: 10.14218/JCTH.2015.00007] [Cited by in Crossref: 28] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
283 Kleiner DE. Histopathological challenges in suspected drug-induced liver injury. Liver Int 2018;38:198-209. [PMID: 28865179 DOI: 10.1111/liv.13584] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
284 Teschke R, Danan G. Diagnosis and Management of Drug-Induced Liver Injury (DILI) in Patients with Pre-Existing Liver Disease. Drug Saf. 2016;39:729-744. [PMID: 27091053 DOI: 10.1007/s40264-016-0423-z] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 9.3] [Reference Citation Analysis]
285 Carr DF, Pirmohamed M. Biomarkers of adverse drug reactions. Exp Biol Med (Maywood) 2018;243:291-9. [PMID: 28950720 DOI: 10.1177/1535370217733425] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
286 Overby CL, Pathak J, Gottesman O, Haerian K, Perotte A, Murphy S, Bruce K, Johnson S, Talwalkar J, Shen Y, Ellis S, Kullo I, Chute C, Friedman C, Bottinger E, Hripcsak G, Weng C. A collaborative approach to developing an electronic health record phenotyping algorithm for drug-induced liver injury. J Am Med Inform Assoc 2013;20:e243-52. [PMID: 23837993 DOI: 10.1136/amiajnl-2013-001930] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 5.0] [Reference Citation Analysis]
287 Devarbhavi H, Dierkhising R, Kremers WK, Sandeep MS, Karanth D, Adarsh CK. Single-center experience with drug-induced liver injury from India: causes, outcome, prognosis, and predictors of mortality. Am J Gastroenterol. 2010;105:2396-2404. [PMID: 20648003 DOI: 10.1038/ajg.2010.287] [Cited by in Crossref: 133] [Cited by in F6Publishing: 104] [Article Influence: 12.1] [Reference Citation Analysis]
288 Wang Y, Lai R, Zong P, Xu Q, Shang J, Zhang X, Zhong W, Tang J, Han X, Chen C, Mao Y. Bicyclol for the treatment of drug-induced liver injury: a propensity score matching analysis using a nationwide inpatient database. J Int Med Res 2021;49:3000605211005945. [PMID: 33853430 DOI: 10.1177/03000605211005945] [Reference Citation Analysis]
289 Hussaini SH, Farrington EA. Idiosyncratic drug-induced liver injury: an update on the 2007 overview. Expert Opin Drug Saf. 2014;13:67-81. [PMID: 24073714 DOI: 10.1517/14740338.2013.828032] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 4.9] [Reference Citation Analysis]
290 Fernández-Murga ML, Petrov PD, Conde I, Castell JV, Goméz-Lechón MJ, Jover R. Advances in drug-induced cholestasis: Clinical perspectives, potential mechanisms and in vitro systems. Food Chem Toxicol 2018;120:196-212. [PMID: 29990576 DOI: 10.1016/j.fct.2018.07.017] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.7] [Reference Citation Analysis]
291 Chen J, Ahmad J. Cefdinir-induced hepatotoxicity: potential hazards of inappropriate antibiotic use. J Gen Intern Med 2008;23:1914-6. [PMID: 18752027 DOI: 10.1007/s11606-008-0758-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
292 Wong MCS, Huang JLW, George J, Huang J, Leung C, Eslam M, Chan HLY, Ng SC. The changing epidemiology of liver diseases in the Asia–Pacific region. Nat Rev Gastroenterol Hepatol 2019;16:57-73. [DOI: 10.1038/s41575-018-0055-0] [Cited by in Crossref: 86] [Cited by in F6Publishing: 70] [Article Influence: 28.7] [Reference Citation Analysis]
293 Pang L, Yang W, Hou F. Features and outcomes from a retrospective study of 570 hospitalized Chinese patients with drug-induced liver injury. Clin Res Hepatol Gastroenterol 2018;42:48-56. [PMID: 28927656 DOI: 10.1016/j.clinre.2017.08.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
294 Teschke R. Hepatology highlights. Annals of Hepatology 2015;14:772-3. [DOI: 10.5604/16652681.1171738] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
295 Ali SE, Waddington JC, Park BK, Meng X. Definition of the Chemical and Immunological Signals Involved in Drug-Induced Liver Injury. Chem Res Toxicol 2020;33:61-76. [PMID: 31682113 DOI: 10.1021/acs.chemrestox.9b00275] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
296 Asrani SK, Devarbhavi H, Eaton J, Kamath PS. Burden of liver diseases in the world. J Hepatol. 2019;70:151-171. [PMID: 30266282 DOI: 10.1016/j.jhep.2018.09.014] [Cited by in Crossref: 615] [Cited by in F6Publishing: 473] [Article Influence: 205.0] [Reference Citation Analysis]
297 Millonig G, Stadlmann S, Vogel W. Herbal hepatotoxicity: acute hepatitis caused by a Noni preparation (Morinda citrifolia). Eur J Gastroenterol Hepatol. 2005;17:445-447. [PMID: 15756098 DOI: 10.1097/00042737-200504000-00009] [Cited by in Crossref: 70] [Cited by in F6Publishing: 51] [Article Influence: 4.4] [Reference Citation Analysis]
298 Miller ED, Abu-sbeih H, Chalasani NP. Drug-Induced Liver Injury in Older Adults. In: Pitchumoni CS, Dharmarajan T, editors. Geriatric Gastroenterology. Cham: Springer International Publishing; 2019. pp. 1-16. [DOI: 10.1007/978-3-319-90761-1_53-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
299 Aithal GP, Day CP. Nonsteroidal anti-inflammatory drug-induced hepatotoxicity. Clin Liver Dis 2007;11:563-75, vi-vii. [PMID: 17723920 DOI: 10.1016/j.cld.2007.06.004] [Cited by in Crossref: 112] [Cited by in F6Publishing: 74] [Article Influence: 8.0] [Reference Citation Analysis]
300 Kredel M, Brederlau J, Roewer N, Wunder C. [Cholestasis and liver dysfunction in critical care patients]. Anaesthesist 2008;57:1172-82. [PMID: 18989650 DOI: 10.1007/s00101-008-1459-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
301 Reike-Kunze M, Zenouzi R, Hartel J, Krech T, Weidemann S, Sterneck M, Weiler-Normann C, Lohse AW, Schramm C, Sebode M. Drug-induced liver injury at a tertiary care centre in Germany: Model for end-stage liver disease is the best predictor of outcome. Liver Int 2021. [PMID: 34152686 DOI: 10.1111/liv.14985] [Reference Citation Analysis]
302 Morisco F, Pagliaro L, Caporaso N, Bianco E, Sagliocca L, Fargion S, Smedile A, Salvagnini M, Mele A. Consensus recommendations for managing asymptomatic persistent non-virus non-alcohol related elevation of aminotransferase levels: suggestions for diagnostic procedures and monitoring. Dig Liver Dis. 2008;40:585-598. [PMID: 18395501 DOI: 10.1016/j.dld.2008.02.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
303 Teschke R, Schwarzenboeck A, Hennermann KH. Causality assessment in hepatotoxicity by drugs and dietary supplements. Br J Clin Pharmacol. 2008;66:758-766. [PMID: 19032721 DOI: 10.1111/j.1365-2125.2008.03264.x] [Cited by in Crossref: 71] [Cited by in F6Publishing: 67] [Article Influence: 5.9] [Reference Citation Analysis]
304 Moole H, Ahmed Z, Saxena N, Puli SR, Dhillon S. Oral clindamycin causing acute cholestatic hepatitis without ductopenia: a brief review of idiosyncratic drug-induced liver injury and a case report. J Community Hosp Intern Med Perspect 2015;5:28746. [PMID: 26486111 DOI: 10.3402/jchimp.v5.28746] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
305 Chen M, Suzuki A, Borlak J, Andrade RJ, Lucena MI. Drug-induced liver injury: Interactions between drug properties and host factors. J Hepatol. 2015;63:503-514. [PMID: 25912521 DOI: 10.1016/j.jhep.2015.04.016] [Cited by in Crossref: 200] [Cited by in F6Publishing: 153] [Article Influence: 33.3] [Reference Citation Analysis]
306 Lee FY, Wong HS, Chan HK, Mohamed Ali N, Abu Hassan MR, Omar H, Abdul Mutalib NA. Hepatic adverse drug reactions in Malaysia: An 18-year review of the national centralized reporting system.Pharmacoepidemiol Drug Saf. 2020;29:1669-1679. [PMID: 33064335 DOI: 10.1002/pds.5153] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
307 Wang YM, Chai SC, Brewer CT, Chen T. Pregnane X receptor and drug-induced liver injury. Expert Opin Drug Metab Toxicol 2014;10:1521-32. [PMID: 25252616 DOI: 10.1517/17425255.2014.963555] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 4.1] [Reference Citation Analysis]
308 Fontana RJ. Acute liver failure including acetaminophen overdose. Med Clin North Am. 2008;92:761-794, viii. [PMID: 18570942 DOI: 10.1016/j.mcna.2008.03.005] [Cited by in Crossref: 136] [Cited by in F6Publishing: 104] [Article Influence: 10.5] [Reference Citation Analysis]
309 Tian QJ, Zhao XY, Wang Y, Wee A, Soon GST, Gouw ASH, Li M, Yang RY, Wang L, Wang QY, Duan WJ, Wang Y, Wang XM, Kong YY, Ou XJ, You H, Jia JD. Histologic pattern is better correlated with clinical outcomes than biochemical classification in patients with drug-induced liver injury. Mod Pathol 2019;32:1795-805. [PMID: 31300804 DOI: 10.1038/s41379-019-0314-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
310 Parlati L, Voican CS, Perlemuter K, Perlemuter G. Aloe vera-induced acute liver injury: A case report and literature review. Clin Res Hepatol Gastroenterol. 2017;41:e39-e42. [PMID: 27856182 DOI: 10.1016/j.clinre.2016.10.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
311 Zhang C, Wu Y, Yuan S, Dou X, Sheng Q, Wang J, Tian W, Yao L, Ding Y. Characteristics of Drug-Induced Liver Injury in Northeast China: Disease Spectrum and Drug Types. Dig Dis Sci 2020;65:3360-8. [PMID: 31907771 DOI: 10.1007/s10620-019-06030-6] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
312 Björnsson ES, Hoofnagle JH. Categorization of drugs implicated in causing liver injury: Critical assessment based on published case reports. Hepatology. 2016;63:590-603. [PMID: 26517184 DOI: 10.1002/hep.28323] [Cited by in Crossref: 121] [Cited by in F6Publishing: 94] [Article Influence: 20.2] [Reference Citation Analysis]
313 Li X, Wang L, Li D, Niu J, Gao P. Dyslipidemia is a Risk Factor for the Incidence and Severity of Drug-Induced Liver Injury (DILI): A Retrospective Population-Based Study in China. Med Sci Monit 2019;25:3344-53. [PMID: 31059494 DOI: 10.12659/MSM.916687] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
314 Tujios SR, Lee WM. Acute liver failure induced by idiosyncratic reaction to drugs: Challenges in diagnosis and therapy. Liver Int. 2018;38:6-14. [PMID: 28771932 DOI: 10.1111/liv.13535] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 7.8] [Reference Citation Analysis]
315 Kuzu UB, Öztaş E, Turhan N, Saygili F, Suna N, Yildiz H, Kaplan M, Akpinar MY, Akdoğan M, Kaçar S, Kiliç ZM, Köksal AŞ, Ödemiş B, Kayaçetin E. Clinical and histological features of idiosyncratic liver injury: Dilemma in diagnosis of autoimmune hepatitis. Hepatol Res 2016;46:277-91. [PMID: 25926402 DOI: 10.1111/hepr.12530] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
316 Jung KA, Min HJ, Yoo SS, Kim HJ, Choi SN, Ha CY, Kim HJ, Kim TH, Jung WT, Lee OJ, Lee JS, Shim SG. Drug-Induced Liver Injury: Twenty Five Cases of Acute Hepatitis Following Ingestion of Polygonum multiflorum Thunb. Gut Liver. 2011;5:493-499. [PMID: 22195249 DOI: 10.5009/gnl.2011.5.4.493] [Cited by in Crossref: 89] [Cited by in F6Publishing: 80] [Article Influence: 8.9] [Reference Citation Analysis]
317 Motola D, Vargiu A, Leone R, Cocci A, Salvo F, Ros B, Meneghelli I, Venegoni M, Cutroneo PM, Vaccheri A, Velo G, Montanaro N. Hepatic adverse drug reactions: a case/non-case study in Italy. Eur J Clin Pharmacol 2007;63:73-9. [PMID: 17119945 DOI: 10.1007/s00228-006-0222-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
318 Teschke R, Frenzel C, Wolff A, Eickhoff A, Schulze J. Drug induced liver injury: accuracy of diagnosis in published reports. Annals of Hepatology 2014;13:248-55. [DOI: 10.1016/s1665-2681(19)30888-9] [Cited by in Crossref: 41] [Article Influence: 5.9] [Reference Citation Analysis]
319 Kleiner DE. The histopathological evaluation of drug-induced liver injury. Histopathology. 2017;70:81-93. [PMID: 27960237 DOI: 10.1111/his.13082] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 4.8] [Reference Citation Analysis]
320 Huang S, Liu M, Fu F, Liu H, He B, Xiao D, Yang J. High Serum Estradiol Reduces Acute Hepatotoxicity Risk Induced by Epirubicin Plus Cyclophosphamide Chemotherapy in Premenopausal Women with Breast Cancer. Front Pharmacol 2020;11:572444. [PMID: 33584258 DOI: 10.3389/fphar.2020.572444] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
321 Russmann S, Jetter A, Kullak-Ublick GA. Pharmacogenetics of drug-induced liver injury. Hepatology. 2010;52:748-761. [PMID: 20607838 DOI: 10.1002/hep.23720] [Cited by in Crossref: 107] [Cited by in F6Publishing: 88] [Article Influence: 9.7] [Reference Citation Analysis]
322 Bell LN, Chalasani N. Epidemiology of idiosyncratic drug-induced liver injury. Semin Liver Dis. 2009;29:337-347. [PMID: 19826967 DOI: 10.1055/s-0029-1240002] [Cited by in Crossref: 126] [Cited by in F6Publishing: 94] [Article Influence: 10.5] [Reference Citation Analysis]
323 Bresteau C, Prevot S, Perlemuter G, Voican C. Methylprednisolone-induced acute liver injury in a patient treated for multiple sclerosis relapse. BMJ Case Rep 2018;2018:bcr-2017-223670. [PMID: 29507031 DOI: 10.1136/bcr-2017-223670] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
324 Sunil Kumar N, Remalayam B, Thomas V, Ramachandran TM, Sunil Kumar K. Outcomes and Predictors of Mortality in Patients With Drug-Induced Liver Injury at a Tertiary Hospital in South India: A Single-Centre Experience. J Clin Exp Hepatol 2021;11:163-70. [PMID: 33746440 DOI: 10.1016/j.jceh.2020.08.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
325 Bernal W, Auzinger G, Dhawan A, Wendon J. Acute liver failure. Lancet. 2010;376:190-201. [PMID: 20638564 DOI: 10.1016/s0140-6736(10)60274-7] [Cited by in Crossref: 614] [Cited by in F6Publishing: 244] [Article Influence: 55.8] [Reference Citation Analysis]
326 Teschke R, Schwarzenboeck A, Eickhoff A, Frenzel C, Wolff A, Schulze J. Clinical and causality assessment in herbal hepatotoxicity. Expert Opin Drug Saf. 2013;12:339-366. [PMID: 23458441 DOI: 10.1517/14740338.2013.774371] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 5.3] [Reference Citation Analysis]
327 Roth SE, Avigan MI, Bourdet D, Brott D, Church R, Dash A, Keller D, Sherratt P, Watkins PB, Westcott-Baker L, Lentini S, Merz M, Ramaiah L, Ramaiah SK, Stanley AM, Marcinak J. Next-Generation DILI Biomarkers: Prioritization of Biomarkers for Qualification and Best Practices for Biospecimen Collection in Drug Development. Clin Pharmacol Ther 2020;107:333-46. [PMID: 31314926 DOI: 10.1002/cpt.1571] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
328 Chalasani N, Bonkovsky HL, Fontana R, Lee W, Stolz A, Talwalkar J, Reddy KR, Watkins PB, Navarro V, Barnhart H, Gu J, Serrano J;  United States Drug Induced Liver Injury Network. Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study. Gastroenterology. 2015;148:1340-1352.e7. [PMID: 25754159 DOI: 10.1053/j.gastro.2015.03.006] [Cited by in Crossref: 380] [Cited by in F6Publishing: 303] [Article Influence: 63.3] [Reference Citation Analysis]
329 Serafini M, Rio D, N’dri Y, Bettuzzi S, Peluso I. Health Benefits of Tea. In: Wachtel-galor S, editor. Herbal Medicine. CRC Press; 2011. pp. 239-61. [DOI: 10.1201/b10787-13] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
330 Daly AK, Donaldson PT, Bhatnagar P, Shen Y, Pe’er I, Floratos A, Daly MJ, Goldstein DB, John S, Nelson MR. HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin. Nat Genet. 2009;41:816-819. [PMID: 19483685 DOI: 10.1038/ng.379] [Cited by in Crossref: 749] [Cited by in F6Publishing: 572] [Article Influence: 62.4] [Reference Citation Analysis]
331 Bleibel W, Kim S, D’silva K, Lemmer ER. Drug-Induced Liver Injury: Review Article. Dig Dis Sci 2007;52:2463-71. [DOI: 10.1007/s10620-006-9472-y] [Cited by in Crossref: 71] [Cited by in F6Publishing: 52] [Article Influence: 5.1] [Reference Citation Analysis]
332 Quintás G, Martínez-Sena T, Conde I, Pareja Ibars E, Kleinjans J, Castell JV. Metabolomic analysis to discriminate drug-induced liver injury (DILI) phenotypes. Arch Toxicol 2021;95:3049-62. [PMID: 34274980 DOI: 10.1007/s00204-021-03114-z] [Reference Citation Analysis]
333 Laverty HG, Antoine DJ, Benson C, Chaponda M, Williams D, Park BK. The potential of cytokines as safety biomarkers for drug-induced liver injury. Eur J Clin Pharmacol 2010;66:961-76. [DOI: 10.1007/s00228-010-0862-x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 3.3] [Reference Citation Analysis]
334 Garcia-Cortes M, Robles-Diaz M, Stephens C, Ortega-Alonso A, Lucena MI, Andrade RJ. Drug induced liver injury: an update.Arch Toxicol. 2020;94:3381-3407. [PMID: 32852569 DOI: 10.1007/s00204-020-02885-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 17.0] [Reference Citation Analysis]
335 Shin J, Hunt CM, Suzuki A, Papay JI, Beach KJ, Cheetham TC. Characterizing phenotypes and outcomes of drug-associated liver injury using electronic medical record data: DRUG-ASSOCIATED LIVER INJURY. Pharmacoepidemiol Drug Saf 2013;22:190-8. [DOI: 10.1002/pds.3388] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
336 Sjouke B, Langslet G, Ceska R, Nicholls SJ, Nissen SE, Öhlander M, Ladenson PW, Olsson AG, Hovingh GK, Kastelein JJ. Eprotirome in patients with familial hypercholesterolaemia (the AKKA trial): a randomised, double-blind, placebo-controlled phase 3 study. Lancet Diabetes Endocrinol 2014;2:455-63. [PMID: 24731671 DOI: 10.1016/S2213-8587(14)70006-3] [Cited by in Crossref: 63] [Cited by in F6Publishing: 24] [Article Influence: 9.0] [Reference Citation Analysis]
337 Jiménez‐pérez M, González‐grande R, García‐cortés M, Andrade RJ. Drug‐Induced Liver Injury After Liver Transplantation. Liver Transpl 2020;26:1167-76. [DOI: 10.1002/lt.25804] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
338 Van Bambeke F, Tulkens PM. Safety Profile of the Respiratory Fluoroquinolone Moxifloxacin: Comparison with Other Fluoroquinolones and Other Antibacterial Classes. Drug Safety 2009;32:359-78. [DOI: 10.2165/00002018-200932050-00001] [Cited by in Crossref: 73] [Cited by in F6Publishing: 65] [Article Influence: 6.1] [Reference Citation Analysis]
339 Licata A, Calvaruso V, Cappello M, Craxì A, Almasio PL. Clinical course and outcomes of drug-induced liver injury: nimesulide as the first implicated medication. Dig Liver Dis. 2010;42:143-148. [PMID: 19625223 DOI: 10.1016/j.dld.2009.06.009] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
340 Andrade RJ, Chalasani N, Björnsson ES, Suzuki A, Kullak-Ublick GA, Watkins PB, Devarbhavi H, Merz M, Lucena MI, Kaplowitz N, Aithal GP. Drug-induced liver injury. Nat Rev Dis Primers 2019;5:58. [PMID: 31439850 DOI: 10.1038/s41572-019-0105-0] [Cited by in Crossref: 81] [Cited by in F6Publishing: 57] [Article Influence: 40.5] [Reference Citation Analysis]
341 Ramm S, Morissey B, Hernandez B, Rooney C, Pennington SR, Mally A. Application of a discovery to targeted LC-MS proteomics approach to identify deregulated proteins associated with idiosyncratic liver toxicity in a rat model of LPS/diclofenac co-administration. Toxicology 2015;331:100-11. [PMID: 25772430 DOI: 10.1016/j.tox.2015.03.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
342 Kaniwa N, Saito Y. Pharmacogenomics of severe cutaneous adverse reactions and drug-induced liver injury. J Hum Genet 2013;58:317-26. [PMID: 23635947 DOI: 10.1038/jhg.2013.37] [Cited by in Crossref: 51] [Cited by in F6Publishing: 32] [Article Influence: 6.4] [Reference Citation Analysis]
343 Suk KT, Kim DJ, Kim CH, Park SH, Yoon JH, Kim YS, Baik GH, Kim JB, Kweon YO, Kim BI, Kim SH, Kim IH, Kim JH, Nam SW, Paik YH, Suh JI, Sohn JH, Ahn BM, Um SH, Lee HJ, Cho M, Jang MK, Choi SK, Hwang SG, Sung HT, Choi JY, Han KH. A prospective nationwide study of drug-induced liver injury in Korea. Am J Gastroenterol. 2012;107:1380-1387. [PMID: 22733303 DOI: 10.1038/ajg.2012.138] [Cited by in Crossref: 127] [Cited by in F6Publishing: 100] [Article Influence: 14.1] [Reference Citation Analysis]
344 Zhou Y, Shen JX, Lauschke VM. Comprehensive Evaluation of Organotypic and Microphysiological Liver Models for Prediction of Drug-Induced Liver Injury. Front Pharmacol 2019;10:1093. [PMID: 31616302 DOI: 10.3389/fphar.2019.01093] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 13.5] [Reference Citation Analysis]
345 Brauer R, Douglas I, Garcia Rodriguez LA, Downey G, Huerta C, de Abajo F, Bate A, Feudjo Tepie M, de Groot MC, Schlienger R, Reynolds R, Smeeth L, Klungel O, Ruigómez A. Risk of acute liver injury associated with use of antibiotics. Comparative cohort and nested case-control studies using two primary care databases in Europe. Pharmacoepidemiol Drug Saf 2016;25 Suppl 1:29-38. [PMID: 27038354 DOI: 10.1002/pds.3861] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
346 Kim JS, Jang YR, Lee JW, Kim JY, Jung YK, Chung DH, Kwon OS, Kim YS, Choi DJ, Kim JH. A case of amoxicillin-induced hepatocellular liver injury with bile-duct damage. Korean J Hepatol. 2011;17:229-232. [PMID: 22102391 DOI: 10.3350/kjhep.2011.17.3.229] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
347 Penman SL, Sharma P, Aerts H, Park BK, Weaver RJ, Chadwick AE. Differential toxic effects of bile acid mixtures in isolated mitochondria and physiologically relevant HepaRG cells. Toxicol In Vitro 2019;61:104595. [PMID: 31288073 DOI: 10.1016/j.tiv.2019.104595] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
348 Muriel P. The Liver. Liver Pathophysiology. Elsevier; 2017. pp. 3-22. [DOI: 10.1016/b978-0-12-804274-8.00001-1] [Cited by in Crossref: 10] [Article Influence: 2.5] [Reference Citation Analysis]
349 Freyer N, Greuel S, Knöspel F, Strahl N, Amini L, Jacobs F, Monshouwer M, Zeilinger K. Effects of Co-Culture Media on Hepatic Differentiation of hiPSC with or without HUVEC Co-Culture. Int J Mol Sci 2017;18:E1724. [PMID: 28783133 DOI: 10.3390/ijms18081724] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
350 Rubenstein JH, Laine L. Systematic review: the hepatotoxicity of non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther. 2004;20:373-380. [PMID: 15298630 DOI: 10.1111/j.1365-2036.2004.02092.x] [Cited by in Crossref: 58] [Cited by in F6Publishing: 45] [Article Influence: 3.4] [Reference Citation Analysis]
351 Teschke R, Eickhoff A. The Honolulu Liver Disease Cluster at the Medical Center: Its Mysteries and Challenges. Int J Mol Sci. 2016;17:476. [PMID: 27043544 DOI: 10.3390/ijms17040476] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 4.6] [Reference Citation Analysis]
352 Hussaini SH, O'Brien CS, Despott EJ, Dalton HR. Antibiotic therapy: a major cause of drug-induced jaundice in southwest England. Eur J Gastroenterol Hepatol 2007;19:15-20. [PMID: 17206072 DOI: 10.1097/01.meg.0000250581.77865.68] [Cited by in Crossref: 61] [Cited by in F6Publishing: 48] [Article Influence: 4.4] [Reference Citation Analysis]
353 Moore N, Duret S, Grolleau A, Lassalle R, Barbet V, Duong M, Thurin N, Droz-perroteau C, Gulmez SE. Previous Drug Exposure in Patients Hospitalised for Acute Liver Injury: A Case-Population Study in the French National Healthcare Data System. Drug Saf 2019;42:559-72. [DOI: 10.1007/s40264-018-0752-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 3.7] [Reference Citation Analysis]
354 Leone R, Conforti A, Venegoni M, Motola D, Moretti U, Meneghelli I, Cocci A, Sangiorgi Cellini G, Scotto S, Montanaro N, Velo G. Drug-induced anaphylaxis : case/non-case study based on an italian pharmacovigilance database. Drug Saf 2005;28:547-56. [PMID: 15924506 DOI: 10.2165/00002018-200528060-00006] [Cited by in Crossref: 45] [Cited by in F6Publishing: 30] [Article Influence: 3.0] [Reference Citation Analysis]
355 Hessheimer AJ, Nacif L, Flores Villalba E, Fondevila C. Liver transplantation for acute liver failure. Cir Esp 2017;95:181-9. [PMID: 28433231 DOI: 10.1016/j.ciresp.2017.01.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
356 Lewis JH. Causality assessment: which is best-expert opinion or RUCAM? Clinical Liver Dis. 2014;4:4-8. [PMID: 30992910 DOI: 10.1002/cld.365] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 2.1] [Reference Citation Analysis]
357 Clarke JI, Dear JW, Antoine DJ. Recent advances in biomarkers and therapeutic interventions for hepatic drug safety – false dawn or new horizon? Expert Opinion on Drug Safety 2016;15:625-34. [DOI: 10.1517/14740338.2016.1160057] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 7.0] [Reference Citation Analysis]
358 Takikawa H. Recent status of drug-induced liver injury. Hepatol Res. 2009;39:1-6. [PMID: 18637144 DOI: 10.1111/j.1872-034X.2008.00400.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
359 Smith ID, Simpson KJ, Garden OJ, Wigmore SJ. Non-paracetamol drug-induced fulminant hepatic failure among adults in Scotland. Eur J Gastroenterol Hepatol 2005;17:161-7. [PMID: 15674093 DOI: 10.1097/00042737-200502000-00006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
360 Mikus M, Drobin K, Gry M, Bachmann J, Lindberg J, Yimer G, Aklillu E, Makonnen E, Aderaye G, Roach J, Fier I, Kampf C, Göpfert J, Perazzo H, Poynard T, Stephens C, Andrade RJ, Lucena MI, Arber N, Uhlén M, Watkins PB, Schwenk JM, Nilsson P, Schuppe-Koistinen I. Elevated levels of circulating CDH5 and FABP1 in association with human drug-induced liver injury. Liver Int 2017;37:132-40. [PMID: 27224670 DOI: 10.1111/liv.13174] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
361 Czaja AJ. Drug-induced autoimmune-like hepatitis. Dig Dis Sci. 2011;56:958-976. [PMID: 21327704 DOI: 10.1007/s10620-011-1611-4] [Cited by in Crossref: 152] [Cited by in F6Publishing: 109] [Article Influence: 15.2] [Reference Citation Analysis]
362 Hernández N, Bessone F, Sánchez A, Pace MD, Brahm J, Zapata R, Chirino RA, Dávalos M, Méndez-sánchez N, Arrese M, Schinoni M, Lucena MI, Andrade RJ. Profile of idiosyncratic drug induced liver injury in Latin America. An analysis of published reports. Annals of Hepatology 2014;13:231-9. [DOI: 10.1016/s1665-2681(19)30886-5] [Cited by in Crossref: 22] [Article Influence: 3.1] [Reference Citation Analysis]
363 Leise MD, Poterucha JJ, Talwalkar JA. Drug-induced liver injury. Mayo Clin Proc. 2014;89:95-106. [PMID: 24388027 DOI: 10.1016/j.mayocp.2013.09.016] [Cited by in Crossref: 208] [Cited by in F6Publishing: 162] [Article Influence: 29.7] [Reference Citation Analysis]
364 Pillans PI, Ghiculescu RA, Lampe G, Wilson R, Wong R, Macdonald GA. Severe acute liver injury associated with lumiracoxib. J Gastroenterol Hepatol. 2012;27:1102-1105. [PMID: 22142375 DOI: 10.1111/j.1440-1746.2011.07036.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.2] [Reference Citation Analysis]
365 Cao L, Quan XB, Zeng WJ, Yang XO, Wang MJ. Mechanism of Hepatocyte Apoptosis. J Cell Death. 2016;9:19-29. [PMID: 28058033 DOI: 10.4137/jcd.s39824] [Cited by in Crossref: 42] [Cited by in F6Publishing: 20] [Article Influence: 8.4] [Reference Citation Analysis]
366 Bell CC, Lauschke VM, Vorrink SU, Palmgren H, Duffin R, Andersson TB, Ingelman-Sundberg M. Transcriptional, Functional, and Mechanistic Comparisons of Stem Cell-Derived Hepatocytes, HepaRG Cells, and Three-Dimensional Human Hepatocyte Spheroids as Predictive In Vitro Systems for Drug-Induced Liver Injury. Drug Metab Dispos 2017;45:419-29. [PMID: 28137721 DOI: 10.1124/dmd.116.074369] [Cited by in Crossref: 96] [Cited by in F6Publishing: 74] [Article Influence: 24.0] [Reference Citation Analysis]
367 Huang SC, Yang HC, Kao JH. Hepatitis B reactivation: diagnosis and management. Expert Rev Gastroenterol Hepatol 2020;14:565-78. [PMID: 32448008 DOI: 10.1080/17474124.2020.1774364] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
368 Katarey D, Verma S. Drug-induced liver injury. Clin Med (Lond) 2016;16:s104-9. [PMID: 27956449 DOI: 10.7861/clinmedicine.16-6-s104] [Cited by in Crossref: 48] [Cited by in F6Publishing: 32] [Article Influence: 12.0] [Reference Citation Analysis]
369 Lee CH, Wang JD, Chen PC. Increased risk of hospitalization for acute hepatitis in patients with previous exposure to NSAIDs. Pharmacoepidemiol Drug Saf 2010;19:708-14. [PMID: 20582911 DOI: 10.1002/pds.1966] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 2.7] [Reference Citation Analysis]
370 Riebensahm C, Ka D, Sow A, Semmo N, Wandeler G. A closer look at the spectrum of drug-induced liver injury in sub-Saharan Africa. Expert Rev Clin Pharmacol 2019;12:875-83. [PMID: 31269818 DOI: 10.1080/17512433.2019.1638251] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
371 Tan EH, Ling ZJ, Ang PS, Sung C, Dan YY, Tai BC. Comparison of laboratory threshold criteria in drug-induced liver injury detection algorithms for use in pharmacovigilance. Pharmacoepidemiol Drug Saf 2020;29:1480-8. [PMID: 32844466 DOI: 10.1002/pds.5099] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
372 Watkins PB. Idiosyncratic drug-induced liver injury in patients: Detection, severity assessment, and regulatory implications. Adv Pharmacol 2019;85:165-93. [PMID: 31307586 DOI: 10.1016/bs.apha.2019.02.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
373 Kim JW, Phongsamran PV. Drug-Induced Liver Disease and Drug Use Considerations in Liver Disease. Journal of Pharmacy Practice 2009;22:278-89. [DOI: 10.1177/0897190008328696] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
374 Kolarić TO, Ninčević V, Smolić R, Smolić M, Wu GY. Mechanisms of Hepatic Cholestatic Drug Injury. J Clin Transl Hepatol 2019;7:86-92. [PMID: 30944824 DOI: 10.14218/JCTH.2018.00042] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
375 Holt M, Ju C. Drug-Induced Liver Injury. In: Uetrecht J, editor. Adverse Drug Reactions. Berlin: Springer Berlin Heidelberg; 2010. pp. 3-27. [DOI: 10.1007/978-3-642-00663-0_1] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
376 Fontana RJ, Watkins PB, Bonkovsky HL, Chalasani N, Davern T, Serrano J, Rochon J. Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct. Drug Saf. 2009;32:55-68. [PMID: 19132805 DOI: 10.2165/00002] [Reference Citation Analysis]
377 Kleiner DE. Liver Injury Due to Drugs and Herbal Agents. Practical Hepatic Pathology: a Diagnostic Approach. Elsevier; 2018. pp. 327-70. [DOI: 10.1016/b978-0-323-42873-6.00023-8] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
378 Suzuki A, Yuen NA, Ilic K, Miller RT, Reese MJ, Brown HR, Ambroso JI, Falls JG, Hunt CM. Comedications alter drug-induced liver injury reporting frequency: Data mining in the WHO VigiBase™. Regul Toxicol Pharmacol 2015;72:481-90. [PMID: 25988394 DOI: 10.1016/j.yrtph.2015.05.004] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
379 Gonzalez HC, Jafri SM, Gordon SC. Management of Acute Hepatotoxicity Including Medical Agents and Liver Support Systems. Clin Liver Dis 2017;21:163-80. [PMID: 27842770 DOI: 10.1016/j.cld.2016.08.012] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
380 Trauner M, Boyer JL. Cholestatic syndromes: . Current Opinion in Gastroenterology 2003;19:216-31. [DOI: 10.1097/00001574-200305000-00005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
381 Grove JI, Aithal GP. Human leukocyte antigen genetic risk factors of drug-induced liver toxicology. Expert Opin Drug Metab Toxicol 2015;11:395-409. [PMID: 25491399 DOI: 10.1517/17425255.2015.992414] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 4.6] [Reference Citation Analysis]
382 Haque T, Sasatomi E, Hayashi PH. Drug-Induced Liver Injury: Pattern Recognition and Future Directions. Gut Liver 2016;10:27-36. [PMID: 26696029 DOI: 10.5009/gnl15114] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
383 Chughlay MF, Kramer N, Werfalli M, Spearman W, Engel ME, Cohen K. N-acetylcysteine for non-paracetamol drug-induced liver injury: a systematic review protocol. Syst Rev 2015;4:84. [PMID: 26066646 DOI: 10.1186/s13643-015-0075-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
384 de Abajo FJ, Montero D, Madurga M, García Rodríguez LA. Acute and clinically relevant drug-induced liver injury: a population based case-control study. Br J Clin Pharmacol 2004;58:71-80. [PMID: 15206996 DOI: 10.1111/j.1365-2125.2004.02133.x] [Cited by in Crossref: 257] [Cited by in F6Publishing: 214] [Article Influence: 15.1] [Reference Citation Analysis]
385 Larrey D, Pageaux GP. Drug-induced acute liver failure. Eur J Gastroenterol Hepatol. 2005;17:141-143. [PMID: 15674089 DOI: 10.1097/00042737-200502000-00002] [Cited by in Crossref: 56] [Cited by in F6Publishing: 36] [Article Influence: 3.5] [Reference Citation Analysis]
386 Wree A, Dechêne A, Herzer K, Hilgard P, Syn WK, Gerken G, Canbay A. Steroid and ursodesoxycholic Acid combination therapy in severe drug-induced liver injury. Digestion 2011;84:54-9. [PMID: 21304237 DOI: 10.1159/000322298] [Cited by in F6Publishing: 39] [Reference Citation Analysis]
387 George N, Chen M, Yuen N, Hunt CM, Suzuki A. Interplay of gender, age and drug properties on reporting frequency of drug-induced liver injury. Regulatory Toxicology and Pharmacology 2018;94:101-7. [DOI: 10.1016/j.yrtph.2018.01.018] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]